{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 9700, "items": [{"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T00:06:40Z", "timestamp": 1574813200174}, "reference-count": 105, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2016, 8, 1]], "date-time": "2016-08-01T00:00:00Z", "timestamp": 1470009600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["clinicalkey.jp", "clinicalkey.com", "clinicalkey.es", "clinicalkey.com.au", "clinicalkey.fr", "bmn.com", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Current Opinion in Immunology"], "published-print": {"date-parts": [[2016, 8]]}, "DOI": "10.1016/j.coi.2016.06.004", "type": "journal-article", "created": {"date-parts": [[2016, 6, 30]], "date-time": "2016-06-30T10:16:17Z", "timestamp": 1467281777000}, "page": "68-76", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 36, "title": ["Chimeric antigen receptors: driving immunology towards synthetic biology"], "prefix": "10.1016", "volume": "41", "author": [{"given": "Michel", "family": "Sadelain", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Current Opinion in Immunology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0952791516300607?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0952791516300607?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 7, 14]], "date-time": "2018-07-14T23:44:59Z", "timestamp": 1531611899000}, "score": 82.86877, "issued": {"date-parts": [[2016, 8]]}, "references-count": 105, "alternative-id": ["S0952791516300607"], "URL": "http://dx.doi.org/10.1016/j.coi.2016.06.004", "ISSN": ["0952-7915"], "issn-type": [{"value": "0952-7915", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Chimeric antigen receptors: driving immunology towards synthetic biology", "name": "articletitle", "label": "Article Title"}, {"value": "Current Opinion in Immunology", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.coi.2016.06.004", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "\u00a9 2016 Published by Elsevier Ltd.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T08:14:13Z", "timestamp": 1574756053891}, "reference-count": 164, "publisher": "Annual Reviews", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Annu. Rev. Cancer Biol."], "published-print": {"date-parts": [[2017, 3, 6]]}, "DOI": "10.1146/annurev-cancerbio-050216-034351", "type": "journal-article", "created": {"date-parts": [[2017, 3, 6]], "date-time": "2017-03-06T22:48:44Z", "timestamp": 1488840524000}, "page": "447-466", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Chimeric Antigen Receptors: A Paradigm Shift in Immunotherapy"], "prefix": "10.1146", "volume": "1", "author": [{"given": "Michel", "family": "Sadelain", "sequence": "first", "affiliation": [{"name": "Memorial Sloan Kettering Cancer Center, New York, NY 10065;"}]}], "member": "22", "container-title": ["Annual Review of Cancer Biology"], "language": "en", "link": [{"URL": "http://www.annualreviews.org/doi/pdf/10.1146/annurev-cancerbio-050216-034351", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 19]], "date-time": "2019-09-19T10:37:14Z", "timestamp": 1568889434000}, "score": 53.139946, "issued": {"date-parts": [[2017, 3, 6]]}, "references-count": 164, "journal-issue": {"published-print": {"date-parts": [[2017, 3, 6]]}, "issue": "1"}, "alternative-id": ["10.1146/annurev-cancerbio-050216-034351"], "URL": "http://dx.doi.org/10.1146/annurev-cancerbio-050216-034351", "ISSN": ["2472-3428"], "issn-type": [{"value": "2472-3428", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T13:55:27Z", "timestamp": 1574776527085}, "reference-count": 154, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2017, 5, 1]], "date-time": "2017-05-01T00:00:00Z", "timestamp": 1493596800000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/", "start": {"date-parts": [[2018, 5, 3]], "date-time": "2018-05-03T00:00:00Z", "timestamp": 1525305600000}, "delay-in-days": 367, "content-version": "vor"}], "content-domain": {"domain": ["cell.com", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Molecular Therapy"], "published-print": {"date-parts": [[2017, 5]]}, "DOI": "10.1016/j.ymthe.2017.03.034", "type": "journal-article", "created": {"date-parts": [[2017, 4, 27]], "date-time": "2017-04-27T01:00:40Z", "timestamp": 1493254840000}, "page": "1117-1124", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 36, "title": ["Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective"], "prefix": "10.1016", "volume": "25", "author": [{"given": "Isabelle", "family": "Rivi\u00e8re", "sequence": "first", "affiliation": []}, {"given": "Michel", "family": "Sadelain", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Molecular Therapy"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1525001617301557?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1525001617301557?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 9, 22]], "date-time": "2019-09-22T03:07:06Z", "timestamp": 1569121626000}, "score": 46.31562, "issued": {"date-parts": [[2017, 5]]}, "references-count": 154, "journal-issue": {"published-print": {"date-parts": [[2017, 5]]}, "issue": "5"}, "alternative-id": ["S1525001617301557"], "URL": "http://dx.doi.org/10.1016/j.ymthe.2017.03.034", "ISSN": ["1525-0016"], "issn-type": [{"value": "1525-0016", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective", "name": "articletitle", "label": "Article Title"}, {"value": "Molecular Therapy", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.ymthe.2017.03.034", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "\u00a9 2017 The American Society of Gene and Cell Therapy.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T22:31:10Z", "timestamp": 1574289070732}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2009, 4, 1]], "date-time": "2009-04-01T00:00:00Z", "timestamp": 1238544000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Current Opinion in Immunology"], "published-print": {"date-parts": [[2009, 4]]}, "DOI": "10.1016/j.coi.2009.02.009", "type": "journal-article", "created": {"date-parts": [[2009, 3, 26]], "date-time": "2009-03-26T10:18:16Z", "timestamp": 1238062696000}, "page": "215-223", "source": "Crossref", "is-referenced-by-count": 246, "title": ["The promise and potential pitfalls of chimeric antigen receptors"], "prefix": "10.1016", "volume": "21", "author": [{"given": "Michel", "family": "Sadelain", "sequence": "first", "affiliation": []}, {"given": "Renier", "family": "Brentjens", "sequence": "additional", "affiliation": []}, {"given": "Isabelle", "family": "Rivi\u00e8re", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Current Opinion in Immunology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0952791509000211?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0952791509000211?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 20]], "date-time": "2018-12-20T21:27:40Z", "timestamp": 1545341260000}, "score": 46.233246, "issued": {"date-parts": [[2009, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2009, 4]]}, "issue": "2"}, "alternative-id": ["S0952791509000211"], "URL": "http://dx.doi.org/10.1016/j.coi.2009.02.009", "ISSN": ["0952-7915"], "issn-type": [{"value": "0952-7915", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T17:43:15Z", "timestamp": 1576863795784}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2012, 4, 15]]}, "DOI": "10.1158/1538-7445.am2012-3499", "type": "proceedings-article", "created": {"date-parts": [[2012, 8, 9]], "date-time": "2012-08-09T22:39:16Z", "timestamp": 1344551956000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 31, "title": ["Abstract 3499: CD56 targeted chimeric antigen receptors for immunotherapy of multiple myeloma"], "prefix": "10.1158", "author": [{"given": "Reuben", "family": "Benjamin", "sequence": "first", "affiliation": []}, {"given": "Maud", "family": "Condomines", "sequence": "additional", "affiliation": []}, {"given": "Gertrude", "family": "Gunset", "sequence": "additional", "affiliation": []}, {"given": "Michel", "family": "Sadelain", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 11, 21]]}, "event": {"name": "Proceedings: AACR 103rd Annual Meeting 2012\u2010\u2010 Mar 31\u2010Apr 4, 2012; Chicago, IL"}, "container-title": ["Immunology"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.AM2012-3499", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T19:06:35Z", "timestamp": 1558206395000}, "score": 45.6211, "issued": {"date-parts": [[2012, 4, 15]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.AM2012-3499"], "URL": "http://dx.doi.org/10.1158/1538-7445.am2012-3499"}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T03:54:50Z", "timestamp": 1575258890841}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "8", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2013, 8, 1]], "date-time": "2013-08-01T00:00:00Z", "timestamp": 1375315200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Experimental Hematology"], "published-print": {"date-parts": [[2013, 8]]}, "DOI": "10.1016/j.exphem.2013.05.298", "type": "journal-article", "created": {"date-parts": [[2013, 8, 2]], "date-time": "2013-08-02T08:57:39Z", "timestamp": 1375433859000}, "page": "S75", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Inhibitory chimeric antigen receptors (iCARs) limit undesirable side effects of T-cell therapies"], "prefix": "10.1016", "volume": "41", "author": [{"given": "Victor", "family": "Fedorov", "sequence": "first", "affiliation": []}, {"given": "Maria", "family": "Themeli", "sequence": "additional", "affiliation": []}, {"given": "Michel", "family": "Sadelain", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Experimental Hematology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0301472X13006541?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0301472X13006541?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 14]], "date-time": "2018-10-14T06:00:17Z", "timestamp": 1539496817000}, "score": 39.110115, "issued": {"date-parts": [[2013, 8]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2013, 8]]}, "issue": "8"}, "alternative-id": ["S0301472X13006541"], "URL": "http://dx.doi.org/10.1016/j.exphem.2013.05.298", "ISSN": ["0301-472X"], "issn-type": [{"value": "0301-472X", "type": "print"}], "subject": ["Genetics", "Cell Biology", "Cancer Research", "Molecular Biology", "Hematology"]}, {"indexed": {"date-parts": [[2019, 12, 18]], "date-time": "2019-12-18T15:03:25Z", "timestamp": 1576681405021}, "reference-count": 86, "publisher": "Massachusetts Medical Society", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["N Engl J Med"], "published-print": {"date-parts": [[2018, 7, 5]]}, "DOI": "10.1056/nejmra1706169", "type": "journal-article", "created": {"date-parts": [[2018, 7, 4]], "date-time": "2018-07-04T21:01:16Z", "timestamp": 1530738076000}, "page": "64-73", "source": "Crossref", "is-referenced-by-count": 219, "title": ["Chimeric Antigen Receptor Therapy"], "prefix": "10.1056", "volume": "379", "author": [{"ORCID": "http://orcid.org/0000-0003-0241-3557", "authenticated-orcid": false, "given": "Carl H.", "family": "June", "sequence": "first", "affiliation": [{"name": "From the Center for Cellular Immunotherapies, Perelman School of Medicine, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia (C.H.J.); and the Center for Cell Engineering, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York (M.S.)."}]}, {"given": "Michel", "family": "Sadelain", "sequence": "additional", "affiliation": [{"name": "From the Center for Cellular Immunotherapies, Perelman School of Medicine, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia (C.H.J.); and the Center for Cell Engineering, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York (M.S.)."}]}], "member": "150", "container-title": ["New England Journal of Medicine"], "language": "en", "link": [{"URL": "http://www.nejm.org/doi/pdf/10.1056/NEJMra1706169", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 20]], "date-time": "2019-10-20T10:26:02Z", "timestamp": 1571567162000}, "score": 37.76387, "issued": {"date-parts": [[2018, 7, 5]]}, "references-count": 86, "journal-issue": {"published-print": {"date-parts": [[2018, 7, 5]]}, "issue": "1"}, "alternative-id": ["10.1056/NEJMra1706169"], "URL": "http://dx.doi.org/10.1056/nejmra1706169", "relation": {"is-supplemented-by": [{"id-type": "doi", "id": "10.1056/NEJMdo005289", "asserted-by": "subject"}]}, "ISSN": ["0028-4793", "1533-4406"], "issn-type": [{"value": "0028-4793", "type": "print"}, {"value": "1533-4406", "type": "electronic"}], "subject": ["General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T05:08:34Z", "timestamp": 1574831314556}, "reference-count": 0, "publisher": "AME Publishing Company", "issue": "S2", "content-domain": {"domain": ["amegroups.com"], "crossmark-restriction": false}, "short-container-title": ["Transl. Cancer Res"], "published-print": {"date-parts": [[2016, 8]]}, "DOI": "10.21037/tcr.2016.08.15", "type": "journal-article", "created": {"date-parts": [[2016, 8, 22]], "date-time": "2016-08-22T05:57:11Z", "timestamp": 1471845431000}, "page": "S221-S225", "update-policy": "http://dx.doi.org/10.21037/ame_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 8, "title": ["Myeloid leukemia switch as immune escape from CD19 chimeric antigen receptor (CAR) therapy"], "prefix": "10.21037", "volume": "5", "author": [{"given": "Fabiana", "family": "Perna", "sequence": "first", "affiliation": []}, {"given": "Michel", "family": "Sadelain", "sequence": "additional", "affiliation": []}], "member": "8611", "published-online": {"date-parts": [[2016, 8]]}, "container-title": ["Translational Cancer Research"], "link": [{"URL": "http://tcr.amegroups.com/article/download/9016/7956", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 11, 8]], "date-time": "2018-11-08T08:30:22Z", "timestamp": 1541665822000}, "score": 37.03588, "issued": {"date-parts": [[2016, 8]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2016, 8]]}, "published-print": {"date-parts": [[2016, 8]]}, "issue": "S2"}, "URL": "http://dx.doi.org/10.21037/tcr.2016.08.15", "ISSN": ["2218-676X", "2219-6803"], "issn-type": [{"value": "2218-676X", "type": "print"}, {"value": "2219-6803", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T23:42:06Z", "timestamp": 1575330126785}, "reference-count": 10, "publisher": "Elsevier BV", "issue": "9", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2018, 9, 1]], "date-time": "2018-09-01T00:00:00Z", "timestamp": 1535760000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Trends in Molecular Medicine"], "published-print": {"date-parts": [[2018, 9]]}, "DOI": "10.1016/j.molmed.2018.06.007", "type": "journal-article", "created": {"date-parts": [[2018, 7, 4]], "date-time": "2018-07-04T12:34:07Z", "timestamp": 1530707647000}, "page": "729-731", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Insights into Chimeric Antigen Receptor Therapy for Chronic Lymphoblastic Leukemia"], "prefix": "10.1016", "volume": "24", "author": [{"given": "Mohamad", "family": "Hamieh", "sequence": "first", "affiliation": []}, {"given": "Michel", "family": "Sadelain", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Trends in Molecular Medicine"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1471491418301242?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1471491418301242?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 8, 23]], "date-time": "2018-08-23T15:19:37Z", "timestamp": 1535037577000}, "score": 37.03588, "issued": {"date-parts": [[2018, 9]]}, "references-count": 10, "journal-issue": {"published-print": {"date-parts": [[2018, 9]]}, "issue": "9"}, "alternative-id": ["S1471491418301242"], "URL": "http://dx.doi.org/10.1016/j.molmed.2018.06.007", "ISSN": ["1471-4914"], "issn-type": [{"value": "1471-4914", "type": "print"}], "subject": ["Molecular Medicine", "Molecular Biology"]}, {"indexed": {"date-parts": [[2019, 12, 18]], "date-time": "2019-12-18T01:03:19Z", "timestamp": 1576630999368}, "reference-count": 242, "publisher": "Springer Science and Business Media LLC", "issue": "7", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2015, 7, 1]], "date-time": "2015-07-01T00:00:00Z", "timestamp": 1435708800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Nat Rev Drug Discov"], "published-print": {"date-parts": [[2015, 7]]}, "DOI": "10.1038/nrd4597", "type": "journal-article", "created": {"date-parts": [[2015, 7, 1]], "date-time": "2015-07-01T07:41:29Z", "timestamp": 1435736489000}, "page": "499-509", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 127, "title": ["The pharmacology of second-generation chimeric antigen receptors"], "prefix": "10.1038", "volume": "14", "author": [{"given": "Sjoukje J. C.", "family": "van der Stegen", "sequence": "first", "affiliation": []}, {"given": "Mohamad", "family": "Hamieh", "sequence": "additional", "affiliation": []}, {"given": "Michel", "family": "Sadelain", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2015, 7, 1]]}, "reference": [{"key": "BFnrd4597_CR1", "doi-asserted-by": "publisher", "first-page": "35", "DOI": "10.1038/nrc971", "volume": "3", "author": "M Sadelain", "year": "2003", "unstructured": "Sadelain, M., Riviere, I. & Brentjens, R. Targeting tumours with genetically enhanced T lymphocytes. Nat. Rev. Cancer 3, 35\u201345 (2003).", "journal-title": "Nat. Rev. Cancer"}, {"key": "BFnrd4597_CR2", "doi-asserted-by": "publisher", "first-page": "431", "DOI": "10.1016/S1535-6108(03)00113-2", "volume": "3", "author": "WY Ho", "year": "2003", "unstructured": "Ho, W. Y., Blattman, J. N., Dossett, M. L., Yee, C. & Greenberg, P. D. Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction. Cancer Cell 3, 431\u2013437 (2003).", "journal-title": "Cancer Cell"}, {"key": "BFnrd4597_CR3", "doi-asserted-by": "crossref", "first-page": "126", "DOI": "10.1126/science.1129003", "volume": "314", "author": "RA Morgan", "year": "2006", "unstructured": "Morgan, R. A. et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314, 126\u2013129 (2006).", "journal-title": "Science"}, {"key": "BFnrd4597_CR4", "doi-asserted-by": "crossref", "first-page": "742", "DOI": "10.1038/mt.2008.300", "volume": "17", "author": "ML Dossett", "year": "2009", "unstructured": "Dossett, M. L. et al. Adoptive immunotherapy of disseminated leukemia with TCR-transduced, CD8+ T cells expressing a known endogenous TCR. Mol. Ther. 17, 742\u2013749 (2009).", "journal-title": "Mol. Ther."}, {"key": "BFnrd4597_CR5", "doi-asserted-by": "crossref", "first-page": "215", "DOI": "10.1016/j.coi.2009.02.009", "volume": "21", "author": "M Sadelain", "year": "2009", "unstructured": "Sadelain, M., Brentjens, R. & Riviere, I. The promise and potential pitfalls of chimeric antigen receptors. Curr. Opin. Immunol. 21, 215\u2013223 (2009).", "journal-title": "Curr. Opin. Immunol."}, {"key": "BFnrd4597_CR6", "doi-asserted-by": "publisher", "first-page": "4817", "DOI": "10.1182/blood-2011-04-348540", "volume": "118", "author": "RJ Brentjens", "year": "2011", "unstructured": "Brentjens, R. J. et al. Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias. Blood 118, 4817\u20134828 (2011).", "journal-title": "Blood"}, {"key": "BFnrd4597_CR7", "doi-asserted-by": "crossref", "first-page": "177ra38", "DOI": "10.1126/scitranslmed.3005930", "volume": "5", "author": "RJ Brentjens", "year": "2013", "unstructured": "Brentjens, R. J. et al. CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. Sci. Transl. Med. 5, 177ra38 (2013). The first report of complete remission in four out of four subjects with ALL following CD19 CAR T cell therapy.", "journal-title": "Sci. Transl. Med."}, {"key": "BFnrd4597_CR8", "doi-asserted-by": "crossref", "first-page": "1509", "DOI": "10.1056/NEJMoa1215134", "volume": "368", "author": "SA Grupp", "year": "2013", "unstructured": "Grupp, S. A. et al. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N. Engl. J. Med. 368, 1509\u20131518 (2013).", "journal-title": "N. Engl. J. Med."}, {"key": "BFnrd4597_CR9", "doi-asserted-by": "crossref", "first-page": "224ra25", "DOI": "10.1126/scitranslmed.3008226", "volume": "6", "author": "ML Davila", "year": "2014", "unstructured": "Davila, M. L. et al. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia. Sci. Transl. Med. 6, 224ra25 (2014).", "journal-title": "Sci. Transl. Med."}, {"key": "BFnrd4597_CR10", "doi-asserted-by": "crossref", "first-page": "517", "DOI": "10.1016/S0140-6736(14)61403-3", "volume": "385", "author": "DW Lee", "year": "2015", "unstructured": "Lee, D. W. et al. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a Phase 1 dose-escalation trial. Lancet 385, 517\u2013528 (2015).", "journal-title": "Lancet"}, {"key": "BFnrd4597_CR11", "doi-asserted-by": "crossref", "first-page": "1507", "DOI": "10.1056/NEJMoa1407222", "volume": "371", "author": "SL Maude", "year": "2014", "unstructured": "Maude, S. L. et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. N. Engl. J. Med. 371, 1507\u20131517 (2014).", "journal-title": "N. Engl. J. Med."}, {"key": "BFnrd4597_CR12", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.7150/jca.2.331", "volume": "2", "author": "DL Porter", "year": "2011", "unstructured": "Porter, D. L., Kalos, M., Zheng, Z., Levine, B. & June, C. Chimeric antigen receptor therapy for B-cell malignancies. J. Cancer 2, 331\u2013332 (2011).", "journal-title": "J. Cancer"}, {"key": "BFnrd4597_CR13", "doi-asserted-by": "crossref", "first-page": "725", "DOI": "10.1056/NEJMoa1103849", "volume": "365", "author": "DL Porter", "year": "2011", "unstructured": "Porter, D. L., Levine, B. L., Kalos, M., Bagg, A. & June, C. H. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N. Engl. J. Med. 365, 725\u2013733 (2011). The first case-report of complete remission in two out of three subjects with CCL following CD19 CAR T cell therapy.", "journal-title": "N. Engl. J. Med."}, {"key": "BFnrd4597_CR14", "doi-asserted-by": "crossref", "first-page": "95ra73", "DOI": "10.1126/scitranslmed.3002842", "volume": "3", "author": "M Kalos", "year": "2011", "unstructured": "Kalos, M. et al. T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci. Transl. Med. 3, 95ra73 (2011).", "journal-title": "Sci. Transl. Med."}, {"key": "BFnrd4597_CR15", "doi-asserted-by": "crossref", "first-page": "2709", "DOI": "10.1182/blood-2011-10-384388", "volume": "119", "author": "JN Kochenderfer", "year": "2012", "unstructured": "Kochenderfer, J. N. et al. B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells. Blood 119, 2709\u20132720 (2012).", "journal-title": "Blood"}, {"key": "BFnrd4597_CR16", "doi-asserted-by": "crossref", "first-page": "70", "DOI": "10.1038/nbt0102-70", "volume": "20", "author": "J Maher", "year": "2002", "unstructured": "Maher, J., Brentjens, R. J., Gunset, G., Riviere, I. & Sadelain, M. Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCR\u03b6 /CD28 receptor. Nat. Biotechnol. 20, 70\u201375 (2002). The first report of sustained T cell expansion and functionality upon repeated exposure to antigen using a second-generation CAR (28\u03b6) transduced in human primary T cells.", "journal-title": "Nat. Biotechnol."}, {"key": "BFnrd4597_CR17", "doi-asserted-by": "crossref", "first-page": "676", "DOI": "10.1038/sj.leu.2403302", "volume": "18", "author": "C Imai", "year": "2004", "unstructured": "Imai, C. et al. Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia. Leukemia 18, 676\u2013684 (2004). The first report of the antitumor efficacy of a BB\u03b6 CAR in an ALL xenograft model.", "journal-title": "Leukemia"}, {"key": "BFnrd4597_CR18", "doi-asserted-by": "crossref", "first-page": "701", "DOI": "10.1038/248701a0", "volume": "248", "author": "RM Zinkernagel", "year": "1974", "unstructured": "Zinkernagel, R. M. & Doherty, P. C. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248, 701\u2013702 (1974).", "journal-title": "Nature"}, {"key": "BFnrd4597_CR19", "doi-asserted-by": "crossref", "first-page": "232", "DOI": "10.1038/320232a0", "volume": "320", "author": "Z Dembic", "year": "1986", "unstructured": "Dembic, Z. et al. Transfer of specificity by murine \u03b1 and \u03b2 T-cell receptor genes. Nature 320, 232\u2013238 (1986).", "journal-title": "Nature"}, {"key": "BFnrd4597_CR20", "doi-asserted-by": "crossref", "first-page": "a002436", "DOI": "10.1101/cshperspect.a002436", "volume": "2", "author": "JS Boomer", "year": "2010", "unstructured": "Boomer, J. S. & Green, J. M. An enigmatic tail of CD28 signaling. Cold Spring Harb. Perspect. Biol. 2, a002436 (2010).", "journal-title": "Cold Spring Harb. Perspect. Biol."}, {"key": "BFnrd4597_CR21", "first-page": "16", "volume": "144", "author": "MK Jenkins", "year": "1990", "unstructured": "Jenkins, M. K., Chen, C. A., Jung, G., Mueller, D. L. & Schwartz, R. H. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J. Immunol. 144, 16\u201322 (1990).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR22", "doi-asserted-by": "crossref", "first-page": "1018", "DOI": "10.1126/science.3278377", "volume": "239", "author": "AM Weissman", "year": "1988", "unstructured": "Weissman, A. M. et al. Molecular cloning of the \u03b6 chain of the T cell antigen receptor. Science 239, 1018\u20131021 (1988).", "journal-title": "Science"}, {"key": "BFnrd4597_CR23", "doi-asserted-by": "crossref", "first-page": "891", "DOI": "10.1016/0092-8674(91)90314-O", "volume": "64", "author": "BA Irving", "year": "1991", "unstructured": "Irving, B. A. & Weiss, A. The cytoplasmic domain of the T cell receptor \u03b6 chain is sufficient to couple to receptor-associated signal transduction pathways. Cell 64, 891\u2013901 (1991).", "journal-title": "Cell"}, {"key": "BFnrd4597_CR24", "doi-asserted-by": "crossref", "first-page": "1037", "DOI": "10.1016/0092-8674(91)90327-U", "volume": "64", "author": "C Romeo", "year": "1991", "unstructured": "Romeo, C. & Seed, B. Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptides. Cell 64, 1037\u20131046 (1991).", "journal-title": "Cell"}, {"key": "BFnrd4597_CR25", "doi-asserted-by": "crossref", "first-page": "8905", "DOI": "10.1073/pnas.88.20.8905", "volume": "88", "author": "F Letourneur", "year": "1991", "unstructured": "Letourneur, F. & Klausner, R. D. T-cell and basophil activation through the cytoplasmic tail of T-cell-receptor \u03b6 family proteins. Proc. Natl Acad. Sci. USA 88, 8905\u20138909 (1991).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4597_CR26", "doi-asserted-by": "crossref", "first-page": "720", "DOI": "10.1073/pnas.90.2.720", "volume": "90", "author": "Z Eshhar", "year": "1993", "unstructured": "Eshhar, Z., Waks, T., Gross, G. & Schindler, D. G. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the \u03b3 or \u03b6 subunits of the immunoglobulin and T-cell receptors. Proc. Natl Acad. Sci. USA 90, 720\u2013724 (1993). This paper shows redirection of T cell hybridoma specificity through the coupling of an scFv to a T cell-activating CD3\u03b6 or Fc\u03b3 receptor domain.", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4597_CR27", "doi-asserted-by": "crossref", "first-page": "1435", "DOI": "10.1002/eji.1830230705", "volume": "23", "author": "T Brocker", "year": "1993", "unstructured": "Brocker, T., Peter, A., Traunecker, A. & Karjalainen, K. New simplified molecular design for functional T cell receptor. Eur. J. Immunol. 23, 1435\u20131439 (1993).", "journal-title": "Eur. J. Immunol."}, {"key": "BFnrd4597_CR28", "doi-asserted-by": "crossref", "first-page": "1653", "DOI": "10.1084/jem.181.5.1653", "volume": "181", "author": "T Brocker", "year": "1995", "unstructured": "Brocker, T. & Karjalainen, K. Signals through T cell receptor-\u03b6 chain alone are insufficient to prime resting T lymphocytes. J. Exp. Med. 181, 1653\u20131659 (1995).", "journal-title": "J. Exp. Med."}, {"key": "BFnrd4597_CR29", "first-page": "1999", "volume": "96", "author": "T Brocker", "year": "2000", "unstructured": "Brocker, T. Chimeric Fv-\u03b6 or Fv-\u025b receptors are not sufficient to induce activation or cytokine production in peripheral T cells. Blood 96, 1999\u20132001 (2000).", "journal-title": "Blood"}, {"key": "BFnrd4597_CR30", "first-page": "952", "volume": "90", "author": "HF Gallardo", "year": "1997", "unstructured": "Gallardo, H. F., Tan, C., Ory, D. & Sadelain, M. Recombinant retroviruses pseudotyped with the vesicular stomatitis virus G glycoprotein mediate both stable gene transfer and pseudotransduction in human peripheral blood lymphocytes. Blood 90, 952\u2013957 (1997).", "journal-title": "Blood"}, {"key": "BFnrd4597_CR31", "doi-asserted-by": "crossref", "first-page": "123", "DOI": "10.1038/sj.neo.7900018", "volume": "1", "author": "MC Gong", "year": "1999", "unstructured": "Gong, M. C. et al. Cancer patient T cells genetically targeted to prostate-specific membrane antigen specifically lyse prostate cancer cells and release cytokines in response to prostate-specific membrane antigen. Neoplasia 1, 123\u2013127 (1999).", "journal-title": "Neoplasia"}, {"key": "BFnrd4597_CR32", "doi-asserted-by": "crossref", "first-page": "619", "DOI": "10.1084/jem.188.4.619", "volume": "188", "author": "A Krause", "year": "1998", "unstructured": "Krause, A. et al. Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes. J. Exp. Med. 188, 619\u2013626 (1998).", "journal-title": "J. Exp. Med."}, {"key": "BFnrd4597_CR33", "first-page": "2791", "volume": "161", "author": "HM Finney", "year": "1998", "unstructured": "Finney, H. M., Lawson, A. D., Bebbington, C. R. & Weir, A. N. Chimeric receptors providing both primary and costimulatory signaling in T cells from a single gene product. J. Immunol. 161, 2791\u20132797 (1998).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR34", "doi-asserted-by": "crossref", "first-page": "6123", "DOI": "10.4049/jimmunol.167.11.6123", "volume": "167", "author": "A Hombach", "year": "2001", "unstructured": "Hombach, A. et al. Tumor-specific T cell activation by recombinant immunoreceptors: CD3\u03b6 signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3\u03b6 signaling receptor molecule. J. Immunol. 167, 6123\u20136131 (2001).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR35", "doi-asserted-by": "crossref", "first-page": "609", "DOI": "10.1126/science.7688139", "volume": "261", "author": "A Shahinian", "year": "1993", "unstructured": "Shahinian, A. et al. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261, 609\u2013612 (1993).", "journal-title": "Science"}, {"key": "BFnrd4597_CR36", "doi-asserted-by": "crossref", "first-page": "227", "DOI": "10.1038/nri3405", "volume": "13", "author": "L Chen", "year": "2013", "unstructured": "Chen, L. & Flies, D. B. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat. Rev. Immunol. 13, 227\u2013242 (2013).", "journal-title": "Nat. Rev. Immunol."}, {"key": "BFnrd4597_CR37", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1038/16717", "volume": "397", "author": "A Hutloff", "year": "1999", "unstructured": "Hutloff, A. et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397, 263\u2013266 (1999).", "journal-title": "Nature"}, {"key": "BFnrd4597_CR38", "doi-asserted-by": "crossref", "first-page": "670", "DOI": "10.1038/ni944", "volume": "4", "author": "N Watanabe", "year": "2003", "unstructured": "Watanabe, N. et al. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat. Immunol. 4, 670\u2013679 (2003).", "journal-title": "Nat. Immunol."}, {"key": "BFnrd4597_CR39", "doi-asserted-by": "crossref", "first-page": "267", "DOI": "10.1038/328267a0", "volume": "328", "author": "JF Brunet", "year": "1987", "unstructured": "Brunet, J. F. et al. A new member of the immunoglobulin superfamily \u2014 CTLA-4. Nature 328, 267\u2013270 (1987).", "journal-title": "Nature"}, {"key": "BFnrd4597_CR40", "doi-asserted-by": "crossref", "first-page": "3887", "DOI": "10.1002/j.1460-2075.1992.tb05481.x", "volume": "11", "author": "Y Ishida", "year": "1992", "unstructured": "Ishida, Y., Agata, Y., Shibahara, K. & Honjo, T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 11, 3887\u20133895 (1992).", "journal-title": "EMBO J."}, {"key": "BFnrd4597_CR41", "doi-asserted-by": "crossref", "first-page": "247", "DOI": "10.1007/BF01561573", "volume": "10", "author": "JA Hansen", "year": "1980", "unstructured": "Hansen, J. A., Martin, P. J. & Nowinski, R. C. Monoclonal-antibodies identifying a novel T-cell antigen and Ia antigens of human-lymphocytes. Immunogenetics 10, 247\u2013260 (1980).", "journal-title": "Immunogenetics"}, {"key": "BFnrd4597_CR42", "doi-asserted-by": "crossref", "first-page": "8573", "DOI": "10.1073/pnas.84.23.8573", "volume": "84", "author": "A Aruffo", "year": "1987", "unstructured": "Aruffo, A. & Seed, B. Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc. Natl Acad. Sci. USA 84, 8573\u20138577 (1987).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4597_CR43", "doi-asserted-by": "crossref", "first-page": "1164", "DOI": "10.1002/eji.1830151204", "volume": "15", "author": "H Yamada", "year": "1985", "unstructured": "Yamada, H. et al. Monoclonal antibody 9.3 and anti-CD11 antibodies define reciprocal subsets of lymphocytes. Eur. J. Immunol. 15, 1164\u20131168 (1985).", "journal-title": "Eur. J. Immunol."}, {"key": "BFnrd4597_CR44", "first-page": "3201", "volume": "144", "author": "JA Gross", "year": "1990", "unstructured": "Gross, J. A., St John, T. & Allison, J. P. The murine homologue of the T lymphocyte antigen CD28. Molecular cloning and cell surface expression. J. Immunol. 144, 3201\u20133210 (1990).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR45", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.1111/j.1600-065X.2009.00775.x", "volume": "229", "author": "H Bour-Jordan", "year": "2009", "unstructured": "Bour-Jordan, H. & Bluestone, J. A. Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells. Immunol. Rev. 229, 41\u201366 (2009).", "journal-title": "Immunol. Rev."}, {"key": "BFnrd4597_CR46", "first-page": "769", "volume": "72", "author": "G Woerly", "year": "2002", "unstructured": "Woerly, G. et al. Human eosinophils express and release IL-13 following CD28-dependent activation. J. Leukoc. Biol. 72, 769\u2013779 (2002).", "journal-title": "J. Leukoc. Biol."}, {"key": "BFnrd4597_CR47", "first-page": "4128", "volume": "138", "author": "D Kozbor", "year": "1987", "unstructured": "Kozbor, D., Moretta, A., Messner, H. A., Moretta, L. & Croce, C. M. Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells. J. Immunol. 138, 4128\u20134132 (1987).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR48", "doi-asserted-by": "crossref", "first-page": "1536", "DOI": "10.1002/1521-4141(200105)31:5<1536::AID-IMMU1536>3.0.CO;2-8", "volume": "31", "author": "K Venuprasad", "year": "2001", "unstructured": "Venuprasad, K. et al. Immunobiology of CD28 expression on human neutrophils. I. CD28 regulates neutrophil migration by modulating CXCR-1 expression. Eur. J. Immunol. 31, 1536\u20131543 (2001).", "journal-title": "Eur. J. Immunol."}, {"key": "BFnrd4597_CR49", "doi-asserted-by": "crossref", "first-page": "907", "DOI": "10.4049/jimmunol.181.2.907", "volume": "181", "author": "JA Williams", "year": "2008", "unstructured": "Williams, J. A. et al. Regulation of thymic NKT cell development by the B7\u2013CD28 costimulatory pathway. J. Immunol. 181, 907\u2013917 (2008).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR50", "doi-asserted-by": "crossref", "first-page": "104", "DOI": "10.1126/science.273.5271.104", "volume": "273", "author": "A Viola", "year": "1996", "unstructured": "Viola, A. & Lanzavecchia, A. T cell activation determined by T cell receptor number and tunable thresholds. Science 273, 104\u2013106 (1996).", "journal-title": "Science"}, {"key": "BFnrd4597_CR51", "first-page": "3827", "volume": "161", "author": "SP Manickasingham", "year": "1998", "unstructured": "Manickasingham, S. P., Anderton, S. M., Burkhart, C. & Wraith, D. C. Qualitative and quantitative effects of CD28/B7-mediated costimulation on naive T cells in vitro. J. Immunol. 161, 3827\u20133835 (1998).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR52", "doi-asserted-by": "crossref", "first-page": "11796", "DOI": "10.1073/pnas.092284399", "volume": "99", "author": "M Diehn", "year": "2002", "unstructured": "Diehn, M. et al. Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation. Proc. Natl Acad. Sci. USA 99, 11796\u201311801 (2002).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4597_CR53", "doi-asserted-by": "crossref", "first-page": "11790", "DOI": "10.1073/pnas.162359999", "volume": "99", "author": "JL Riley", "year": "2002", "unstructured": "Riley, J. L. et al. Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc. Natl Acad. Sci. USA 99, 11790\u201311795 (2002).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4597_CR54", "doi-asserted-by": "crossref", "first-page": "4472", "DOI": "10.1128/MCB.7.12.4472", "volume": "7", "author": "CH June", "year": "1987", "unstructured": "June, C. H., Ledbetter, J. A., Gillespie, M. M., Lindsten, T. & Thompson, C. B. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell. Biol. 7, 4472\u20134481 (1987).", "journal-title": "Mol. Cell. Biol."}, {"key": "BFnrd4597_CR55", "doi-asserted-by": "crossref", "first-page": "12", "DOI": "10.1186/1471-2172-13-12", "volume": "13", "author": "RL Smeets", "year": "2012", "unstructured": "Smeets, R. L. et al. Molecular pathway profiling of T lymphocyte signal transduction pathways; Th1 and Th2 genomic fingerprints are defined by TCR and CD28-mediated signaling. BMC Immunol. 13, 12 (2012).", "journal-title": "BMC Immunol."}, {"key": "BFnrd4597_CR56", "doi-asserted-by": "crossref", "first-page": "789", "DOI": "10.1002/(SICI)1521-4141(199903)29:03<789::AID-IMMU789>3.0.CO;2-5", "volume": "29", "author": "GJ Boonen", "year": "1999", "unstructured": "Boonen, G. J. et al. CD28 induces cell cycle progression by IL-2-independent down-regulation of p27kip1 expression in human peripheral T lymphocytes. Eur. J. Immunol. 29, 789\u2013798 (1999).", "journal-title": "Eur. J. Immunol."}, {"key": "BFnrd4597_CR57", "first-page": "1788", "volume": "156", "author": "LG Radvanyi", "year": "1996", "unstructured": "Radvanyi, L. G. et al. CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response. J. Immunol. 156, 1788\u20131798 (1996).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR58", "doi-asserted-by": "crossref", "first-page": "4639", "DOI": "10.4049/jimmunol.174.8.4639", "volume": "174", "author": "RM Thomas", "year": "2005", "unstructured": "Thomas, R. M., Gao, L. & Wells, A. D. Signals from CD28 induce stable epigenetic modification of the IL-2 promoter. J. Immunol. 174, 4639\u20134646 (2005).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR59", "doi-asserted-by": "crossref", "first-page": "1064", "DOI": "10.1038/ni.2687", "volume": "14", "author": "PM Gubser", "year": "2013", "unstructured": "Gubser, P. M. et al. Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch. Nat. Immunol. 14, 1064\u20131072 (2013).", "journal-title": "Nat. Immunol."}, {"key": "BFnrd4597_CR60", "doi-asserted-by": "crossref", "first-page": "1043", "DOI": "10.1016/j.immuni.2013.09.015", "volume": "39", "author": "K Yang", "year": "2013", "unstructured": "Yang, K. et al. T cell exit from quiescence and differentiation into Th2 cells depend on Raptor-mTORC1-mediated metabolic reprogramming. Immunity 39, 1043\u20131056 (2013).", "journal-title": "Immunity"}, {"key": "BFnrd4597_CR61", "doi-asserted-by": "crossref", "first-page": "27366", "DOI": "10.1074/jbc.271.44.27366", "volume": "271", "author": "M Faris", "year": "1996", "unstructured": "Faris, M., Kokot, N., Lee, L. & Nel, A. E. Regulation of interleukin-2 transcription by inducible stable expression of dominant negative and dominant active mitogen-activated protein kinase kinase kinase in jurkat T cells. Evidence for the importance of Ras in a pathway that is controlled by dual receptor stimulation. J. Biol. Chem. 271, 27366\u201327373 (1996).", "journal-title": "J. Biol. Chem."}, {"key": "BFnrd4597_CR62", "doi-asserted-by": "crossref", "first-page": "3724", "DOI": "10.4049/jimmunol.170.7.3724", "volume": "170", "author": "S Rao", "year": "2003", "unstructured": "Rao, S., Gerondakis, S., Woltring, D. & Shannon, M. F. c-Rel is required for chromatin remodeling across the IL-2 gene promoter. J. Immunol. 170, 3724\u20133731 (2003).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR63", "doi-asserted-by": "crossref", "first-page": "1081", "DOI": "10.1038/sj.emboj.7601012", "volume": "25", "author": "A Murayama", "year": "2006", "unstructured": "Murayama, A. et al. A specific CpG site demethylation in the human interleukin 2 gene promoter is an epigenetic memory. EMBO J. 25, 1081\u20131092 (2006).", "journal-title": "EMBO J."}, {"key": "BFnrd4597_CR64", "doi-asserted-by": "crossref", "first-page": "205", "DOI": "10.1016/S1074-7613(01)00103-0", "volume": "14", "author": "JL Grogan", "year": "2001", "unstructured": "Grogan, J. L. et al. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 14, 205\u2013215 (2001).", "journal-title": "Immunity"}, {"key": "BFnrd4597_CR65", "doi-asserted-by": "crossref", "first-page": "4476", "DOI": "10.4049/jimmunol.180.7.4476", "volume": "180", "author": "SR Jacobs", "year": "2008", "unstructured": "Jacobs, S. R. et al. Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. J. Immunol. 180, 4476\u20134486 (2008).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR66", "doi-asserted-by": "crossref", "first-page": "769", "DOI": "10.1016/S1074-7613(02)00323-0", "volume": "16", "author": "KA Frauwirth", "year": "2002", "unstructured": "Frauwirth, K. A. et al. The CD28 signaling pathway regulates glucose metabolism. Immunity 16, 769\u2013777 (2002).", "journal-title": "Immunity"}, {"key": "BFnrd4597_CR67", "doi-asserted-by": "crossref", "first-page": "37", "DOI": "10.1038/83144", "volume": "2", "author": "LP Kane", "year": "2001", "unstructured": "Kane, L. P., Andres, P. G., Howland, K. C., Abbas, A. K. & Weiss, A. Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-\u03b3 but not TH2 cytokines. Nat. Immunol. 2, 37\u201344 (2001).", "journal-title": "Nat. Immunol."}, {"key": "BFnrd4597_CR68", "doi-asserted-by": "crossref", "first-page": "6869", "DOI": "10.4049/jimmunol.167.12.6869", "volume": "167", "author": "JC Rathmell", "year": "2001", "unstructured": "Rathmell, J. C., Farkash, E. A., Gao, W. & Thompson, C. B. IL-7 enhances the survival and maintains the size of naive T cells. J. Immunol. 167, 6869\u20136876 (2001).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR69", "doi-asserted-by": "crossref", "first-page": "5899", "DOI": "10.1128/MCB.21.17.5899-5912.2001", "volume": "21", "author": "MG Vander Heiden", "year": "2001", "unstructured": "Vander Heiden, M. G. et al. Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol. Cell. Biol. 21, 5899\u20135912 (2001).", "journal-title": "Mol. Cell. Biol."}, {"key": "BFnrd4597_CR70", "doi-asserted-by": "crossref", "first-page": "683", "DOI": "10.1016/S1097-2765(00)00066-6", "volume": "6", "author": "JC Rathmell", "year": "2000", "unstructured": "Rathmell, J. C., Vander Heiden, M. G., Harris, M. H., Frauwirth, K. A. & Thompson, C. B. In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability. Mol. Cell 6, 683\u2013692 (2000).", "journal-title": "Mol. Cell"}, {"key": "BFnrd4597_CR71", "doi-asserted-by": "crossref", "first-page": "939", "DOI": "10.1038/nri1248", "volume": "3", "author": "O Acuto", "year": "2003", "unstructured": "Acuto, O. & Michel, F. CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat. Rev. Immunol. 3, 939\u2013951 (2003).", "journal-title": "Nat. Rev. Immunol."}, {"key": "BFnrd4597_CR72", "doi-asserted-by": "crossref", "first-page": "87", "DOI": "10.1016/1074-7613(95)90161-2", "volume": "3", "author": "LH Boise", "year": "1995", "unstructured": "Boise, L. H. et al. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3, 87\u201398 (1995).", "journal-title": "Immunity"}, {"key": "BFnrd4597_CR73", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1016/S1074-7613(03)00053-0", "volume": "18", "author": "YY Wan", "year": "2003", "unstructured": "Wan, Y. Y. & DeGregori, J. The survival of antigen-stimulated T cells requires NF\u03baB-mediated inhibition of p73 expression. Immunity 18, 331\u2013342 (2003).", "journal-title": "Immunity"}, {"key": "BFnrd4597_CR74", "doi-asserted-by": "crossref", "first-page": "2765", "DOI": "10.1002/1521-4141(200010)30:10<2765::AID-IMMU2765>3.0.CO;2-W", "volume": "30", "author": "S Kirchhoff", "year": "2000", "unstructured": "Kirchhoff, S., Muller, W. W., Li-Weber, M. & Krammer, P. H. Up-regulation of c-FLIPshort and reduction of activation-induced cell death in CD28-costimulated human T cells. Eur. J. Immunol. 30, 2765\u20132774 (2000).", "journal-title": "Eur. J. Immunol."}, {"key": "BFnrd4597_CR75", "doi-asserted-by": "crossref", "first-page": "6586", "DOI": "10.1073/pnas.90.14.6586", "volume": "90", "author": "CD Gimmi", "year": "1993", "unstructured": "Gimmi, C. D., Freeman, G. J., Gribben, J. G., Gray, G. & Nadler, L. M. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc. Natl Acad. Sci. USA 90, 6586\u20136590 (1993).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4597_CR76", "doi-asserted-by": "crossref", "first-page": "3707", "DOI": "10.1002/1521-4141(200012)30:12<3707::AID-IMMU3707>3.0.CO;2-Q", "volume": "30", "author": "KC Beier", "year": "2000", "unstructured": "Beier, K. C. et al. Induction, binding specificity and function of human ICOS. Eur. J. Immunol. 30, 3707\u20133717 (2000).", "journal-title": "Eur. J. Immunol."}, {"key": "BFnrd4597_CR77", "doi-asserted-by": "crossref", "first-page": "1083", "DOI": "10.1093/intimm/10.8.1083", "volume": "10", "author": "C Johnson-Leger", "year": "1998", "unstructured": "Johnson-Leger, C., Christensen, J. & Klaus, G. G. CD28 co-stimulation stabilizes the expression of the CD40 ligand on T cells. Int. Immunol. 10, 1083\u20131091 (1998).", "journal-title": "Int. Immunol."}, {"key": "BFnrd4597_CR78", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1016/S0014-5793(03)00326-0", "volume": "541", "author": "JO Kim", "year": "2003", "unstructured": "Kim, J. O., Kim, H. W., Baek, K. M. & Kang, C. Y. NF-\u03baB and AP-1 regulate activation-dependent CD137 (4-1BB) expression in T cells. FEBS Lett. 541, 163\u2013170 (2003).", "journal-title": "FEBS Lett."}, {"key": "BFnrd4597_CR79", "doi-asserted-by": "crossref", "first-page": "6494", "DOI": "10.4049/jimmunol.179.10.6494", "volume": "179", "author": "AB Borowski", "year": "2007", "unstructured": "Borowski, A. B. et al. Memory CD8+ T cells require CD28 costimulation. J. Immunol. 179, 6494\u20136503 (2007).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR80", "doi-asserted-by": "crossref", "first-page": "1148", "DOI": "10.4049/jimmunol.180.2.1148", "volume": "180", "author": "S Fuse", "year": "2008", "unstructured": "Fuse, S., Zhang, W. & Usherwood, E. J. Control of memory CD8+ T cell differentiation by CD80/CD86-CD28 costimulation and restoration by IL-2 during the recall response. J. Immunol. 180, 1148\u20131157 (2008).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR81", "doi-asserted-by": "crossref", "first-page": "631", "DOI": "10.1084/jem.180.2.631", "volume": "180", "author": "KS Hathcock", "year": "1994", "unstructured": "Hathcock, K. S., Laszlo, G., Pucillo, C., Linsley, P. & Hodes, R. J. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J. Exp. Med. 180, 631\u2013640 (1994).", "journal-title": "J. Exp. Med."}, {"key": "BFnrd4597_CR82", "doi-asserted-by": "crossref", "first-page": "592", "DOI": "10.1046/j.1365-2567.1996.d01-785.x", "volume": "89", "author": "J Fleischer", "year": "1996", "unstructured": "Fleischer, J. et al. Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes. Immunology 89, 592\u2013598 (1996).", "journal-title": "Immunology"}, {"key": "BFnrd4597_CR83", "doi-asserted-by": "crossref", "first-page": "1497", "DOI": "10.1097/00007890-199711270-00025", "volume": "64", "author": "SC Eck", "year": "1997", "unstructured": "Eck, S. C., Chang, D., Wells, A. D. & Turka, L. A. Differential down-regulation of CD28 by B7-1 and B7-2 engagement. Transplantation 64, 1497\u20131499 (1997).", "journal-title": "Transplantation"}, {"key": "BFnrd4597_CR84", "doi-asserted-by": "crossref", "first-page": "29130", "DOI": "10.1074/jbc.M402194200", "volume": "279", "author": "DE Lewis", "year": "2004", "unstructured": "Lewis, D. E., Merched-Sauvage, M., Goronzy, J. J., Weyand, C. M. & Vallejo, A. N. Tumor necrosis factor-\u03b1 and CD80 modulate CD28 expression through a similar mechanism of T-cell receptor-independent inhibition of transcription. J. Biol. Chem. 279, 29130\u201329138 (2004).", "journal-title": "J. Biol. Chem."}, {"key": "BFnrd4597_CR85", "doi-asserted-by": "crossref", "first-page": "853", "DOI": "10.1189/jlb.0107065", "volume": "83", "author": "M Berg", "year": "2008", "unstructured": "Berg, M. & Zavazava, N. Regulation of CD28 expression on CD8+ T cells by CTLA-4. J. Leukoc. Biol. 83, 853\u2013863 (2008).", "journal-title": "J. Leukoc. Biol."}, {"key": "BFnrd4597_CR86", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1016/j.cellimm.2009.01.003", "volume": "256", "author": "M Habib-Agahi", "year": "2009", "unstructured": "Habib-Agahi, M., Jaberipour, M. & Searle, P. F. 4-1BBL costimulation retrieves CD28 expression in activated T cells. Cell. Immunol. 256, 39\u201346 (2009).", "journal-title": "Cell. Immunol."}, {"key": "BFnrd4597_CR87", "doi-asserted-by": "crossref", "first-page": "947", "DOI": "10.1084/jem.20021288", "volume": "198", "author": "MS Topp", "year": "2003", "unstructured": "Topp, M. S. et al. Restoration of CD28 expression in CD28\u2212 CD8+ memory effector T cells reconstitutes antigen-induced IL-2 production. J. Exp. Med. 198, 947\u2013955 (2003).", "journal-title": "J. Exp. Med."}, {"key": "BFnrd4597_CR88", "doi-asserted-by": "crossref", "first-page": "2049", "DOI": "10.1084/jem.180.6.2049", "volume": "180", "author": "RJ Peach", "year": "1994", "unstructured": "Peach, R. J. et al. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1. J. Exp. Med. 180, 2049\u20132058 (1994).", "journal-title": "J. Exp. Med."}, {"key": "BFnrd4597_CR89", "doi-asserted-by": "crossref", "first-page": "793", "DOI": "10.1016/S1074-7613(94)80021-9", "volume": "1", "author": "PS Linsley", "year": "1994", "unstructured": "Linsley, P. S. et al. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1, 793\u2013801 (1994).", "journal-title": "Immunity"}, {"key": "BFnrd4597_CR90", "doi-asserted-by": "crossref", "first-page": "600", "DOI": "10.1126/science.1202947", "volume": "332", "author": "OS Qureshi", "year": "2011", "unstructured": "Qureshi, O. S. et al. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 332, 600\u2013603 (2011).", "journal-title": "Science"}, {"key": "BFnrd4597_CR91", "doi-asserted-by": "crossref", "first-page": "945", "DOI": "10.4049/jimmunol.173.2.945", "volume": "173", "author": "JM Chemnitz", "year": "2004", "unstructured": "Chemnitz, J. M., Parry, R. V., Nichols, K. E., June, C. H. & Riley, J. L. SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J. Immunol. 173, 945\u2013954 (2004).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR92", "doi-asserted-by": "crossref", "first-page": "682", "DOI": "10.1038/nature04444", "volume": "439", "author": "DL Barber", "year": "2006", "unstructured": "Barber, D. L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682\u2013687 (2006).", "journal-title": "Nature"}, {"key": "BFnrd4597_CR93", "doi-asserted-by": "crossref", "first-page": "114", "DOI": "10.1111/j.1600-065X.2009.00767.x", "volume": "229", "author": "JL Riley", "year": "2009", "unstructured": "Riley, J. L. PD-1 signaling in primary T cells. Immunol. Rev. 229, 114\u2013125 (2009).", "journal-title": "Immunol. Rev."}, {"key": "BFnrd4597_CR94", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1016/S1359-6101(03)00025-X", "volume": "14", "author": "M Croft", "year": "2003", "unstructured": "Croft, M. Costimulation of T cells by OX40, 4-1BB, and CD27. Cytokine Growth Factor Rev. 14, 265\u2013273 (2003).", "journal-title": "Cytokine Growth Factor Rev."}, {"key": "BFnrd4597_CR95", "doi-asserted-by": "crossref", "first-page": "2896", "DOI": "10.1073/pnas.84.9.2896", "volume": "84", "author": "BS Kwon", "year": "1987", "unstructured": "Kwon, B. S. et al. Isolation and initial characterization of multiple species of T-lymphocyte subset cDNA clones. Proc. Natl Acad. Sci. USA 84, 2896\u20132900 (1987).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4597_CR96", "doi-asserted-by": "crossref", "first-page": "1963", "DOI": "10.1073/pnas.86.6.1963", "volume": "86", "author": "BS Kwon", "year": "1989", "unstructured": "Kwon, B. S. & Weissman, S. M. cDNA sequences of two inducible T-cell genes. Proc. Natl Acad. Sci. USA 86, 1963\u20131967 (1989).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4597_CR97", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1016/0378-1119(93)90110-O", "volume": "134", "author": "H Schwarz", "year": "1993", "unstructured": "Schwarz, H., Tuckwell, J. & Lotz, M. A receptor induced by lymphocyte activation (ILA): a new member of the human nerve-growth-factor/tumor-necrosis-factor receptor family. Gene 134, 295\u2013298 (1993).", "journal-title": "Gene"}, {"key": "BFnrd4597_CR98", "first-page": "1043", "volume": "85", "author": "H Schwarz", "year": "1995", "unstructured": "Schwarz, H., Valbracht, J., Tuckwell, J., von Kempis, J. & Lotz, M. ILA, the human 4-1BB homologue, is inducible in lymphoid and other cell lineages. Blood 85, 1043\u20131052 (1995).", "journal-title": "Blood"}, {"key": "BFnrd4597_CR99", "doi-asserted-by": "crossref", "first-page": "1839", "DOI": "10.1002/eji.201242842", "volume": "43", "author": "SJ Lee", "year": "2013", "unstructured": "Lee, S. J. et al. 4-1BB signal stimulates the activation, expansion, and effector functions of \u03b3\u03b4 T cells in mice and humans. Eur. J. Immunol. 43, 1839\u20131848 (2013).", "journal-title": "Eur. J. Immunol."}, {"key": "BFnrd4597_CR100", "doi-asserted-by": "crossref", "first-page": "167", "DOI": "10.1006/cimm.1998.1396", "volume": "190", "author": "I Melero", "year": "1998", "unstructured": "Melero, I., Johnston, J. V., Shufford, W. W., Mittler, R. S. & Chen, L. NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies. Cell. Immunol. 190, 167\u2013172 (1998).", "journal-title": "Cell. Immunol."}, {"key": "BFnrd4597_CR101", "doi-asserted-by": "crossref", "first-page": "787", "DOI": "10.4049/jimmunol.0901619", "volume": "184", "author": "X Zhang", "year": "2010", "unstructured": "Zhang, X. et al. CD137 promotes proliferation and survival of human B cells. J. Immunol. 184, 787\u2013795 (2010).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR102", "doi-asserted-by": "crossref", "first-page": "4262", "DOI": "10.4049/jimmunol.168.9.4262", "volume": "168", "author": "RA Wilcox", "year": "2002", "unstructured": "Wilcox, R. A. et al. Cutting edge: expression of functional CD137 receptor by dendritic cells. J. Immunol. 168, 4262\u20134267 (2002).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR103", "doi-asserted-by": "crossref", "first-page": "456", "DOI": "10.1096/fj.05-4739com", "volume": "21", "author": "D Drenkard", "year": "2007", "unstructured": "Drenkard, D. et al. CD137 is expressed on blood vessel walls at sites of inflammation and enhances monocyte migratory activity. FASEB J. 21, 456\u2013463 (2007).", "journal-title": "FASEB J."}, {"key": "BFnrd4597_CR104", "doi-asserted-by": "crossref", "first-page": "394", "DOI": "10.1016/S1063-4584(97)80044-1", "volume": "5", "author": "J von Kempis", "year": "1997", "unstructured": "von Kempis, J., Schwarz, H. & Lotz, M. Differentiation-dependent and stimulus-specific expression of ILA, the human 4-1BB-homologue, in cells of mesenchymal origin. Osteoarthritis Cartilage 5, 394\u2013406 (1997).", "journal-title": "Osteoarthritis Cartilage"}, {"key": "BFnrd4597_CR105", "doi-asserted-by": "crossref", "first-page": "275", "DOI": "10.1093/intimm/14.3.275", "volume": "14", "author": "T Futagawa", "year": "2002", "unstructured": "Futagawa, T. et al. Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells. Int. Immunol. 14, 275\u2013286 (2002).", "journal-title": "Int. Immunol."}, {"key": "BFnrd4597_CR106", "doi-asserted-by": "crossref", "first-page": "2631", "DOI": "10.1002/eji.1830231037", "volume": "23", "author": "RG Goodwin", "year": "1993", "unstructured": "Goodwin, R. G. et al. Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor. Eur. J. Immunol. 23, 2631\u20132641 (1993).", "journal-title": "Eur. J. Immunol."}, {"key": "BFnrd4597_CR107", "doi-asserted-by": "crossref", "first-page": "367", "DOI": "10.1002/eji.1830240215", "volume": "24", "author": "KE Pollok", "year": "1994", "unstructured": "Pollok, K. E. et al. 4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-\u03bc-primed splenic B cells. Eur. J. Immunol. 24, 367\u2013374 (1994).", "journal-title": "Eur. J. Immunol."}, {"key": "BFnrd4597_CR108", "doi-asserted-by": "crossref", "first-page": "2219", "DOI": "10.1002/eji.1830240943", "volume": "24", "author": "MR Alderson", "year": "1994", "unstructured": "Alderson, M. R. et al. Molecular and biological characterization of human 4-1BB and its ligand. Eur. J. Immunol. 24, 2219\u20132227 (1994).", "journal-title": "Eur. J. Immunol."}, {"key": "BFnrd4597_CR109", "doi-asserted-by": "crossref", "first-page": "1374", "DOI": "10.1111/j.1365-2222.2007.02785.x", "volume": "37", "author": "T Polte", "year": "2007", "unstructured": "Polte, T., Jagemann, A., Foell, J., Mittler, R. S. & Hansen, G. CD137 ligand prevents the development of T-helper type 2 cell-mediated allergic asthma by interferon-\u03b3-producing CD8+ T cells. Clin. Exp. Allergy 37, 1374\u20131385 (2007).", "journal-title": "Clin. Exp. Allergy"}, {"key": "BFnrd4597_CR110", "doi-asserted-by": "crossref", "first-page": "9202", "DOI": "10.1074/jbc.M109.084442", "volume": "285", "author": "EY Won", "year": "2010", "unstructured": "Won, E. Y. et al. The structure of the trimer of human 4-1BB ligand is unique among members of the tumor necrosis factor superfamily. J. Biol. Chem. 285, 9202\u20139210 (2010).", "journal-title": "J. Biol. Chem."}, {"key": "BFnrd4597_CR111", "doi-asserted-by": "crossref", "first-page": "726", "DOI": "10.1007/s00109-006-0072-2", "volume": "84", "author": "DS Vinay", "year": "2006", "unstructured": "Vinay, D. S., Cha, K. & Kwon, B. S. Dual immunoregulatory pathways of 4-1BB signaling. J. Mol. Med. (Berl.) 84, 726\u2013736 (2006).", "journal-title": "J. Mol. Med. (Berl.)"}, {"key": "BFnrd4597_CR112", "doi-asserted-by": "crossref", "first-page": "743", "DOI": "10.1002/eji.200324278", "volume": "34", "author": "W Dawicki", "year": "2004", "unstructured": "Dawicki, W. & Watts, T. H. Expression and function of 4-1BB during CD4 versus CD8 T cell responses in vivo. Eur. J. Immunol. 34, 743\u2013751 (2004).", "journal-title": "Eur. J. Immunol."}, {"key": "BFnrd4597_CR113", "first-page": "5037", "volume": "162", "author": "C Takahashi", "year": "1999", "unstructured": "Takahashi, C., Mittler, R. S. & Vella, A. T. Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal. J. Immunol. 162, 5037\u20135040 (1999).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR114", "doi-asserted-by": "crossref", "first-page": "4464", "DOI": "10.4049/jimmunol.177.7.4464", "volume": "177", "author": "SW Lee", "year": "2006", "unstructured": "Lee, S. W. et al. Functional dichotomy between OX40 and 4-1BB in modulating effector CD8 T cell responses. J. Immunol. 177, 4464\u20134472 (2006).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR115", "doi-asserted-by": "crossref", "first-page": "2739", "DOI": "10.4049/jimmunol.176.5.2739", "volume": "176", "author": "G Pulle", "year": "2006", "unstructured": "Pulle, G., Vidric, M. & Watts, T. H. IL-15-dependent induction of 4-1BB promotes antigen-independent CD8 memory T cell survival. J. Immunol. 176, 2739\u20132748 (2006).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR116", "doi-asserted-by": "crossref", "first-page": "1898", "DOI": "10.4049/jimmunol.174.4.1898", "volume": "174", "author": "KO Nam", "year": "2005", "unstructured": "Nam, K. O. et al. Cross-linking of 4-1BB activates TCR-signaling pathways in CD8+ T lymphocytes. J. Immunol. 174, 1898\u20131905 (2005).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR117", "first-page": "2903", "volume": "133", "author": "I Daniel-Meshulam", "year": "2013", "unstructured": "Daniel-Meshulam, I., Horovitz-Fried, M. & Cohen, C. J. Enhanced antitumor activity mediated by human 4-1BB-engineered T cells. Int. J. Cancer 133, 2903\u20132913 (2013).", "journal-title": "Int. J. Cancer"}, {"key": "BFnrd4597_CR118", "doi-asserted-by": "crossref", "first-page": "1313", "DOI": "10.4049/jimmunol.167.3.1313", "volume": "167", "author": "JL Cannons", "year": "2001", "unstructured": "Cannons, J. L. et al. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy. J. Immunol. 167, 1313\u20131324 (2001).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR119", "doi-asserted-by": "crossref", "first-page": "4897", "DOI": "10.4049/jimmunol.168.10.4897", "volume": "168", "author": "T Wen", "year": "2002", "unstructured": "Wen, T., Bukczynski, J. & Watts, T. H. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function. J. Immunol. 168, 4897\u20134906 (2002).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR120", "doi-asserted-by": "crossref", "first-page": "613", "DOI": "10.1006/bbrc.1997.8016", "volume": "242", "author": "IK Jang", "year": "1998", "unstructured": "Jang, I. K., Lee, Z. H., Kim, Y. J., Kim, S. H. & Kwon, B. S. Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-\u03baB. Biochem. Biophys. Res. Commun. 242, 613\u2013620 (1998).", "journal-title": "Biochem. Biophys. Res. Commun."}, {"key": "BFnrd4597_CR121", "doi-asserted-by": "crossref", "first-page": "558", "DOI": "10.1128/MCB.18.1.558", "volume": "18", "author": "RH Arch", "year": "1998", "unstructured": "Arch, R. H. & Thompson, C. B. 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor \u03baB. Mol. Cell. Biol. 18, 558\u2013565 (1998).", "journal-title": "Mol. Cell. Biol."}, {"key": "BFnrd4597_CR122", "doi-asserted-by": "crossref", "first-page": "1849", "DOI": "10.1084/jem.187.11.1849", "volume": "187", "author": "K Saoulli", "year": "1998", "unstructured": "Saoulli, K. et al. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand. J. Exp. Med. 187, 1849\u20131862 (1998).", "journal-title": "J. Exp. Med."}, {"key": "BFnrd4597_CR123", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1016/j.molcel.2010.03.009", "volume": "38", "author": "C Zheng", "year": "2010", "unstructured": "Zheng, C., Kabaleeswaran, V., Wang, Y., Cheng, G. & Wu, H. Crystal structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 complexes: affinity, specificity, and regulation. Mol. Cell 38, 101\u2013113 (2010).", "journal-title": "Mol. Cell"}, {"key": "BFnrd4597_CR124", "doi-asserted-by": "crossref", "first-page": "8093", "DOI": "10.4049/jimmunol.180.12.8093", "volume": "180", "author": "L Sabbagh", "year": "2008", "unstructured": "Sabbagh, L., Pulle, G., Liu, Y., Tsitsikov, E. N. & Watts, T. H. ERK-dependent Bim modulation downstream of the 4-1BB-TRAF1 signaling axis is a critical mediator of CD8 T cell survival in vivo. J. Immunol. 180, 8093\u20138101 (2008).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR125", "doi-asserted-by": "crossref", "first-page": "23010", "DOI": "10.1074/jbc.M112.350538", "volume": "287", "author": "AJ McPherson", "year": "2012", "unstructured": "McPherson, A. J., Snell, L. M., Mak, T. W. & Watts, T. H. Opposing roles for TRAF1 in the alternative versus classical NF-\u03baB pathway in T cells. J. Biol. Chem. 287, 23010\u201323019 (2012).", "journal-title": "J. Biol. Chem."}, {"key": "BFnrd4597_CR126", "doi-asserted-by": "crossref", "first-page": "6193", "DOI": "10.4049/jimmunol.165.11.6193", "volume": "165", "author": "JL Cannons", "year": "2000", "unstructured": "Cannons, J. L., Choi, Y. & Watts, T. H. Role of TNF receptor-associated factor 2 and p38 mitogen-activated protein kinase activation during 4-1BB-dependent immune response. J. Immunol. 165, 6193\u20136204 (2000).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR127", "doi-asserted-by": "crossref", "first-page": "2874", "DOI": "10.1073/pnas.0500187102", "volume": "102", "author": "J Hauer", "year": "2005", "unstructured": "Hauer, J. et al. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-\u03baB pathway by TRAF-binding TNFRs. Proc. Natl Acad. Sci. USA 102, 2874\u20132879 (2005).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4597_CR128", "doi-asserted-by": "crossref", "first-page": "2133", "DOI": "10.1002/eji.200323996", "volume": "33", "author": "HW Lee", "year": "2003", "unstructured": "Lee, H. W., Nam, K. O., Park, S. J. & Kwon, B. S. 4-1BB enhances CD8+ T cell expansion by regulating cell cycle progression through changes in expression of cyclins D and E and cyclin-dependent kinase inhibitor p27kip1. Eur. J. Immunol. 33, 2133\u20132141 (2003).", "journal-title": "Eur. J. Immunol."}, {"key": "BFnrd4597_CR129", "first-page": "551", "volume": "158", "author": "MA DeBenedette", "year": "1997", "unstructured": "DeBenedette, M. A., Shahinian, A., Mak, T. W. & Watts, T. H. Costimulation of CD28\u2212 T lymphocytes by 4-1BB ligand. J. Immunol. 158, 551\u2013559 (1997).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR130", "first-page": "3081", "volume": "158", "author": "NR Chu", "year": "1997", "unstructured": "Chu, N. R., DeBenedette, M. A., Stiernholm, B. J., Barber, B. H. & Watts, T. H. Role of IL-12 and 4-1BB ligand in cytokine production by CD28+ and CD28\u2212 T cells. J. Immunol. 158, 3081\u20133089 (1997).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR131", "doi-asserted-by": "crossref", "first-page": "446", "DOI": "10.1002/immu.200310020", "volume": "33", "author": "J Bukczynski", "year": "2003", "unstructured": "Bukczynski, J., Wen, T. & Watts, T. H. Costimulation of human CD28\u2212 T cells by 4-1BB ligand. Eur. J. Immunol. 33, 446\u2013454 (2003).", "journal-title": "Eur. J. Immunol."}, {"key": "BFnrd4597_CR132", "doi-asserted-by": "crossref", "first-page": "190", "DOI": "10.1111/j.0105-2896.2005.00262.x", "volume": "205", "author": "M Fann", "year": "2005", "unstructured": "Fann, M. et al. Gene expression characteristics of CD28null memory phenotype CD8+ T cells and its implication in T-cell aging. Immunol. Rev. 205, 190\u2013206 (2005).", "journal-title": "Immunol. Rev."}, {"key": "BFnrd4597_CR133", "first-page": "998", "volume": "10", "author": "HT Ahmad", "year": "2014", "unstructured": "Ahmad, H. T., Mansooreh, J., Fereshteh, M. & Mojtaba, H. Changes in lymphocytes' telomerase activity by 4-1BB costimulation. J. Cancer Res. Ther. 10, 998\u20131003 (2014).", "journal-title": "J. Cancer Res. Ther."}, {"key": "BFnrd4597_CR134", "doi-asserted-by": "crossref", "first-page": "1665", "DOI": "10.4049/jimmunol.175.3.1665", "volume": "175", "author": "J Hendriks", "year": "2005", "unstructured": "Hendriks, J. et al. During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion. J. Immunol. 175, 1665\u20131676 (2005).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR135", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1084/jem.186.1.47", "volume": "186", "author": "WW Shuford", "year": "1997", "unstructured": "Shuford, W. W. et al. 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J. Exp. Med. 186, 47\u201355 (1997).", "journal-title": "J. Exp. Med."}, {"key": "BFnrd4597_CR136", "doi-asserted-by": "crossref", "first-page": "333", "DOI": "10.1016/j.it.2007.06.001", "volume": "28", "author": "L Sabbagh", "year": "2007", "unstructured": "Sabbagh, L., Snell, L. M. & Watts, T. H. TNF family ligands define niches for T cell memory. Trends Immunol. 28, 333\u2013339 (2007).", "journal-title": "Trends Immunol."}, {"key": "BFnrd4597_CR137", "first-page": "4833", "volume": "163", "author": "MA DeBenedette", "year": "1999", "unstructured": "DeBenedette, M. A. et al. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus. J. Immunol. 163, 4833\u20134841 (1999).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR138", "doi-asserted-by": "crossref", "first-page": "5483", "DOI": "10.4049/jimmunol.168.11.5483", "volume": "168", "author": "BS Kwon", "year": "2002", "unstructured": "Kwon, B. S. et al. Immune responses in 4-1BB (CD137)-deficient mice. J. Immunol. 168, 5483\u20135490 (2002).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR139", "doi-asserted-by": "crossref", "first-page": "23", "DOI": "10.1146/annurev.immunol.23.021704.115839", "volume": "23", "author": "TH Watts", "year": "2005", "unstructured": "Watts, T. H. TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23, 23\u201368 (2005).", "journal-title": "Annu. Rev. Immunol."}, {"key": "BFnrd4597_CR140", "doi-asserted-by": "crossref", "first-page": "2762", "DOI": "10.1002/eji.200940256", "volume": "40", "author": "IR Humphreys", "year": "2010", "unstructured": "Humphreys, I. R. et al. Biphasic role of 4-1BB in the regulation of mouse cytomegalovirus-specific CD8+ T cells. Eur. J. Immunol. 40, 2762\u20132768 (2010).", "journal-title": "Eur. J. Immunol."}, {"key": "BFnrd4597_CR141", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1084/jem.20110675", "volume": "209", "author": "C Wang", "year": "2012", "unstructured": "Wang, C. et al. Loss of the signaling adaptor TRAF1 causes CD8+ T cell dysregulation during human and murine chronic infection. J. Exp. Med. 209, 77\u201391 (2012).", "journal-title": "J. Exp. Med."}, {"key": "BFnrd4597_CR142", "doi-asserted-by": "crossref", "first-page": "1383", "DOI": "10.1093/intimm/dxm106", "volume": "19", "author": "M Habib-Agahi", "year": "2007", "unstructured": "Habib-Agahi, M., Phan, T. T. & Searle, P. F. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells. Int. Immunol. 19, 1383\u20131394 (2007).", "journal-title": "Int. Immunol."}, {"key": "BFnrd4597_CR143", "doi-asserted-by": "crossref", "first-page": "4770", "DOI": "10.4049/jimmunol.0902713", "volume": "184", "author": "B Zhang", "year": "2010", "unstructured": "Zhang, B., Zhang, Y., Niu, L., Vella, A. T. & Mittler, R. S. Dendritic cells and Stat3 are essential for CD137-induced CD8 T cell activation-induced cell death. J. Immunol. 184, 4770\u20134778 (2010).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR144", "doi-asserted-by": "crossref", "first-page": "4843", "DOI": "10.1182/blood-2008-05-155945", "volume": "112", "author": "C Frecha", "year": "2008", "unstructured": "Frecha, C. et al. Stable transduction of quiescent T cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins. Blood 112, 4843\u20134852 (2008).", "journal-title": "Blood"}, {"key": "BFnrd4597_CR145", "doi-asserted-by": "crossref", "first-page": "1735", "DOI": "10.1084/jem.189.11.1735", "volume": "189", "author": "D Unutmaz", "year": "1999", "unstructured": "Unutmaz, D., KewalRamani, V. N., Marmon, S. & Littman, D. R. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J. Exp. Med. 189, 1735\u20131746 (1999).", "journal-title": "J. Exp. Med."}, {"key": "BFnrd4597_CR146", "doi-asserted-by": "crossref", "first-page": "5426", "DOI": "10.1158/1078-0432.CCR-07-0674", "volume": "13", "author": "RJ Brentjens", "year": "2007", "unstructured": "Brentjens, R. J. et al. Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts. Clin. Cancer Res. 13, 5426\u20135435 (2007).", "journal-title": "Clin. Cancer Res."}, {"key": "BFnrd4597_CR147", "doi-asserted-by": "crossref", "first-page": "3360", "DOI": "10.1073/pnas.0813101106", "volume": "106", "author": "C Carpenito", "year": "2009", "unstructured": "Carpenito, C. et al. Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains. Proc. Natl Acad. Sci. USA 106, 3360\u20133365 (2009).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4597_CR148", "doi-asserted-by": "crossref", "first-page": "1453", "DOI": "10.1038/mt.2009.83", "volume": "17", "author": "MC Milone", "year": "2009", "unstructured": "Milone, M. C. et al. Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo. Mol. Ther. 17, 1453\u20131464 (2009).", "journal-title": "Mol. Ther."}, {"key": "BFnrd4597_CR149", "doi-asserted-by": "crossref", "first-page": "75", "DOI": "10.1089/hum.2009.122", "volume": "21", "author": "S Tammana", "year": "2010", "unstructured": "Tammana, S. et al. 4-1BB and CD28 signaling plays a synergistic role in redirecting umbilical cord blood T cells against B-cell malignancies. Hum. Gene Ther. 21, 75\u201386 (2010).", "journal-title": "Hum. Gene Ther."}, {"key": "BFnrd4597_CR150", "doi-asserted-by": "crossref", "first-page": "413", "DOI": "10.1038/mt.2009.210", "volume": "18", "author": "XS Zhong", "year": "2010", "unstructured": "Zhong, X. S., Matsushita, M., Plotkin, J., Riviere, I. & Sadelain, M. Chimeric antigen receptors combining 4-1BB and CD28 signaling domains augment PI3kinase/AKT/Bcl-XL activation and CD8+ T cell-mediated tumor eradication. Mol. Ther. 18, 413\u2013420 (2010).", "journal-title": "Mol. Ther."}, {"key": "BFnrd4597_CR151", "doi-asserted-by": "crossref", "first-page": "696", "DOI": "10.1182/blood-2011-03-344275", "volume": "119", "author": "DG Song", "year": "2012", "unstructured": "Song, D. G. et al. CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo. Blood 119, 696\u2013706 (2012).", "journal-title": "Blood"}, {"key": "BFnrd4597_CR152", "doi-asserted-by": "crossref", "first-page": "68", "DOI": "10.1158/2326-6066.CIR-14-0192", "volume": "3", "author": "SP Santoro", "year": "2014", "unstructured": "Santoro, S. P. et al. T cells bearing a chimeric antigen receptor against prostate-specific membrane antigen mediate vascular disruption and result in tumor regression. Cancer Immunol. Res. 3, 68\u201384 (2014).", "journal-title": "Cancer Immunol. Res."}, {"key": "BFnrd4597_CR153", "doi-asserted-by": "crossref", "first-page": "104", "DOI": "10.4049/jimmunol.172.1.104", "volume": "172", "author": "HM Finney", "year": "2004", "unstructured": "Finney, H. M., Akbar, A. N. & Lawson, A. D. Activation of resting human primary T cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR\u03b6 chain. J. Immunol. 172, 104\u2013113 (2004).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR154", "doi-asserted-by": "crossref", "first-page": "1070", "DOI": "10.1182/blood-2013-10-535245", "volume": "124", "author": "S Guedan", "year": "2014", "unstructured": "Guedan, S. et al. ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells. Blood 124, 1070\u20131080 (2014).", "journal-title": "Blood"}, {"key": "BFnrd4597_CR155", "doi-asserted-by": "crossref", "first-page": "2935", "DOI": "10.1002/ijc.25960", "volume": "129", "author": "AA Hombach", "year": "2011", "unstructured": "Hombach, A. A. & Abken, H. Costimulation by chimeric antigen receptors revisited the T cell antitumor response benefits from combined CD28\u2013OX40 signalling. Int. J. Cancer 129, 2935\u20132944 (2011).", "journal-title": "Int. J. Cancer"}, {"key": "BFnrd4597_CR156", "doi-asserted-by": "crossref", "first-page": "5451", "DOI": "10.4049/jimmunol.1490019", "volume": "192", "author": "SA Rosenberg", "year": "2014", "unstructured": "Rosenberg, S. A. IL-2: the first effective immunotherapy for human cancer. J. Immunol. 192, 5451\u20135458 (2014).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR157", "doi-asserted-by": "crossref", "first-page": "1819", "DOI": "10.1038/sj.leu.2404366", "volume": "20", "author": "A Loskog", "year": "2006", "unstructured": "Loskog, A. et al. Addition of the CD28 signaling domain to chimeric T-cell receptors enhances chimeric T-cell resistance to T regulatory cells. Leukemia 20, 1819\u20131828 (2006).", "journal-title": "Leukemia"}, {"key": "BFnrd4597_CR158", "doi-asserted-by": "crossref", "first-page": "760", "DOI": "10.1038/mt.2011.9", "volume": "19", "author": "DM Kofler", "year": "2011", "unstructured": "Kofler, D. M. et al. CD28 costimulation impairs the efficacy of a redirected T-cell antitumor attack in the presence of regulatory T cells which can be overcome by preventing Lck activation. Mol. Ther. 19, 760\u2013767 (2011).", "journal-title": "Mol. Ther."}, {"key": "BFnrd4597_CR159", "doi-asserted-by": "crossref", "first-page": "4133", "DOI": "10.1182/blood-2011-12-400044", "volume": "119", "author": "HJ Pegram", "year": "2012", "unstructured": "Pegram, H. J. et al. Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning. Blood 119, 4133\u20134141 (2012).", "journal-title": "Blood"}, {"key": "BFnrd4597_CR160", "doi-asserted-by": "crossref", "first-page": "2006", "DOI": "10.1038/mt.2010.185", "volume": "18", "author": "J Sun", "year": "2010", "unstructured": "Sun, J. et al. T cells expressing constitutively active Akt resist multiple tumor-associated inhibitory mechanisms. Mol. Ther. 18, 2006\u20132017 (2010).", "journal-title": "Mol. Ther."}, {"key": "BFnrd4597_CR161", "doi-asserted-by": "crossref", "first-page": "356", "DOI": "10.1158/2326-6066.CIR-14-0186", "volume": "3", "author": "MJ Frigault", "year": "2015", "unstructured": "Frigault, M. J. et al. Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cells. Cancer Immunol. Res. 3, 356\u2013367 (2015).", "journal-title": "Cancer Immunol. Res."}, {"key": "BFnrd4597_CR162", "doi-asserted-by": "crossref", "first-page": "12", "DOI": "10.1097/CJI.0000000000000061", "volume": "38", "author": "T Gargett", "year": "2015", "unstructured": "Gargett, T., Fraser, C. K., Dotti, G., Yvon, E. S. & Brown, M. P. BRAF and MEK inhibition variably affect GD2-specific chimeric antigen receptor (CAR) T-cell function in vitro. J. Immunother. 38, 12\u201323 (2015).", "journal-title": "J. Immunother."}, {"key": "BFnrd4597_CR163", "doi-asserted-by": "crossref", "first-page": "4617", "DOI": "10.1158/0008-5472.CAN-11-0422", "volume": "71", "author": "DG Song", "year": "2011", "unstructured": "Song, D. G. et al. In vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB). Cancer Res. 71, 4617\u20134627 (2011).", "journal-title": "Cancer Res."}, {"key": "BFnrd4597_CR164", "doi-asserted-by": "crossref", "first-page": "356", "DOI": "10.1111/j.1600-065X.2009.00778.x", "volume": "229", "author": "K Chattopadhyay", "year": "2009", "unstructured": "Chattopadhyay, K. et al. Sequence, structure, function, immunity: structural genomics of costimulation. Immunol. Rev. 229, 356\u2013386 (2009).", "journal-title": "Immunol. Rev."}, {"key": "BFnrd4597_CR165", "doi-asserted-by": "crossref", "first-page": "581", "DOI": "10.1038/nm.3838", "volume": "21", "author": "AH Long", "year": "2015", "unstructured": "Long, A. H., et al. 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors. Nat. Med. 21, 581\u2013590 (2015).", "journal-title": "Nat. Med."}, {"key": "BFnrd4597_CR166", "doi-asserted-by": "crossref", "first-page": "3654", "DOI": "10.4049/jimmunol.1302148", "volume": "92", "author": "EJ Cheadle", "year": "2014", "unstructured": "Cheadle, E. J. et al. Differential role of Th1 and Th2 cytokines in autotoxicity driven by CD19-specific second-generation chimeric antigen receptor T cells in a mouse model. J. Immunol. 92, 3654\u20133665 (2014).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR167", "doi-asserted-by": "crossref", "first-page": "279", "DOI": "10.1038/nm827", "volume": "9", "author": "RJ Brentjens", "year": "2003", "unstructured": "Brentjens, R. J. et al. Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15. Nat. Med. 9, 279\u2013286 (2003). The first report demonstrating the therapeutic efficacy of human CD19 CAR T cells in mice with systemic B cell malignancies.", "journal-title": "Nat. Med."}, {"key": "BFnrd4597_CR168", "doi-asserted-by": "crossref", "first-page": "e61338", "DOI": "10.1371/journal.pone.0061338", "volume": "8", "author": "ML Davila", "year": "2013", "unstructured": "Davila, M. L., Kloss, C. C., Gunset, G. & Sadelain, M. CD19 CAR-targeted T cells induce long-term remission and B cell aplasia in an immunocompetent mouse model of B cell acute lymphoblastic leukemia. PLoS ONE 8, e61338 (2013).", "journal-title": "PLoS ONE"}, {"key": "BFnrd4597_CR169", "doi-asserted-by": "crossref", "first-page": "261ra151", "DOI": "10.1126/scitranslmed.3010162", "volume": "6", "author": "PS Adusumilli", "year": "2014", "unstructured": "Adusumilli, P. S. et al. Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity. Sci. Transl. Med. 6, 261ra151 (2014).", "journal-title": "Sci. Transl. Med."}, {"key": "BFnrd4597_CR170", "doi-asserted-by": "crossref", "first-page": "1398", "DOI": "10.1172/JCI33522", "volume": "118", "author": "B Zhang", "year": "2008", "unstructured": "Zhang, B., Karrison, T., Rowley, D. A. & Schreiber, H. IFN-\u03b3- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers. J. Clin. Invest. 118, 1398\u20131404 (2008).", "journal-title": "J. Clin. Invest."}, {"key": "BFnrd4597_CR171", "doi-asserted-by": "crossref", "first-page": "361", "DOI": "10.1038/nature11824", "volume": "494", "author": "H Braumuller", "year": "2013", "unstructured": "Braumuller, H. et al. T-helper-1-cell cytokines drive cancer into senescence. Nature 494, 361\u2013365 (2013).", "journal-title": "Nature"}, {"key": "BFnrd4597_CR172", "doi-asserted-by": "crossref", "first-page": "26", "DOI": "10.1158/2326-6066.CIR-14-0098", "volume": "3", "author": "H Matsushita", "year": "2015", "unstructured": "Matsushita, H. et al. Cytotoxic T lymphocytes block tumor growth both by lytic activity and \u03b3-dependent cell-cycle arrest. Cancer Immunol. Res. 3, 26\u201336 (2015).", "journal-title": "Cancer Immunol. Res."}, {"key": "BFnrd4597_CR173", "doi-asserted-by": "crossref", "first-page": "10995", "DOI": "10.1158/0008-5472.CAN-06-0160", "volume": "66", "author": "CM Kowolik", "year": "2006", "unstructured": "Kowolik, C. M. et al. CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells. Cancer Res. 66, 10995\u201311004 (2006).", "journal-title": "Cancer Res."}, {"key": "BFnrd4597_CR174", "doi-asserted-by": "crossref", "first-page": "7710", "DOI": "10.4049/jimmunol.178.12.7710", "volume": "178", "author": "FJ Plunkett", "year": "2007", "unstructured": "Plunkett, F. J. et al. The loss of telomerase activity in highly differentiated CD8+CD28\u2212CD27\u2212 T cells is associated with decreased Akt (Ser473) phosphorylation. J. Immunol. 178, 7710\u20137719 (2007).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR175", "doi-asserted-by": "crossref", "first-page": "5636", "DOI": "10.1158/1078-0432.CCR-13-0458", "volume": "19", "author": "LB John", "year": "2013", "unstructured": "John, L. B. et al. Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cells. Clin. Cancer Res. 19, 5636\u20135646 (2013).", "journal-title": "Clin. Cancer Res."}, {"key": "BFnrd4597_CR176", "doi-asserted-by": "crossref", "first-page": "1160", "DOI": "10.1038/leu.2010.75", "volume": "24", "author": "V Hoyos", "year": "2010", "unstructured": "Hoyos, V. et al. Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety. Leukemia 24, 1160\u20131170 (2010).", "journal-title": "Leukemia"}, {"key": "BFnrd4597_CR177", "doi-asserted-by": "crossref", "first-page": "2246", "DOI": "10.1172/JCI73639", "volume": "124", "author": "A Gros", "year": "2014", "unstructured": "Gros, A. et al. PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors. J. Clin. Invest. 124, 2246\u20132259 (2014).", "journal-title": "J. Clin. Invest."}, {"key": "BFnrd4597_CR178", "doi-asserted-by": "crossref", "first-page": "473", "DOI": "10.1158/2326-6066.CIR-14-0195", "volume": "3", "author": "I Liadi", "year": "2015", "unstructured": "Liadi, I. et al. Individual motile CD4+ T cells can participate in efficient multikilling through conjugation to multiple tumor cells. Cancer Immunol. Res. 3, 473\u2013482 (2015).", "journal-title": "Cancer Immunol. Res."}, {"key": "BFnrd4597_CR179", "doi-asserted-by": "crossref", "first-page": "264", "DOI": "10.1111/imr.12135", "volume": "257", "author": "JG Crompton", "year": "2014", "unstructured": "Crompton, J. G., Sukumar, M. & Restifo, N. P. Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy. Immunol. Rev. 257, 264\u2013276 (2014).", "journal-title": "Immunol. Rev."}, {"key": "BFnrd4597_CR180", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1097/PPO.0000000000000036", "volume": "20", "author": "SR Riddell", "year": "2014", "unstructured": "Riddell, S. R. et al. Adoptive therapy with chimeric antigen receptor-modified T cells of defined subset composition. Cancer J. 20, 141\u2013144 (2014).", "journal-title": "Cancer J."}, {"key": "BFnrd4597_CR181", "doi-asserted-by": "crossref", "first-page": "951", "DOI": "10.1084/jem.178.3.951", "volume": "178", "author": "YS Li", "year": "1993", "unstructured": "Li, Y. S., Hayakawa, K. & Hardy, R. R. The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver. J. Exp. Med. 178, 951\u2013960 (1993).", "journal-title": "J. Exp. Med."}, {"key": "BFnrd4597_CR182", "doi-asserted-by": "crossref", "first-page": "527", "DOI": "10.1016/S1074-7613(00)80268-X", "volume": "5", "author": "YS Li", "year": "1996", "unstructured": "Li, Y. S., Wasserman, R., Hayakawa, K. & Hardy, R. R. Identification of the earliest B lineage stage in mouse bone marrow. Immunity 5, 527\u2013535 (1996).", "journal-title": "Immunity"}, {"key": "BFnrd4597_CR183", "doi-asserted-by": "crossref", "first-page": "1637", "DOI": "10.1182/blood-2002-07-1989", "volume": "101", "author": "LJ Cooper", "year": "2003", "unstructured": "Cooper, L. J. et al. T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect. Blood 101, 1637\u20131644 (2003).", "journal-title": "Blood"}, {"key": "BFnrd4597_CR184", "doi-asserted-by": "crossref", "first-page": "432", "DOI": "10.1038/mt.2011.1", "volume": "19", "author": "DB Kohn", "year": "2011", "unstructured": "Kohn, D. B. et al. CARs on track in the clinic. Mol. Ther. 19, 432\u2013438 (2011).", "journal-title": "Mol. Ther."}, {"key": "BFnrd4597_CR185", "doi-asserted-by": "crossref", "first-page": "1245", "DOI": "10.1016/j.bbmt.2010.03.014", "volume": "16", "author": "MC Jensen", "year": "2010", "unstructured": "Jensen, M. C. et al. Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans. Biol. Blood Marrow Transplant 16, 1245\u20131256 (2010).", "journal-title": "Biol. Blood Marrow Transplant"}, {"key": "BFnrd4597_CR186", "doi-asserted-by": "crossref", "first-page": "4099", "DOI": "10.1182/blood-2010-04-281931", "volume": "116", "author": "JN Kochenderfer", "year": "2010", "unstructured": "Kochenderfer, J. N. et al. Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19. Blood 116, 4099\u20134102 (2010). The first case-report of a remission following CD19 CAR T cell therapy in a subject with a B cell lymphoma.", "journal-title": "Blood"}, {"key": "BFnrd4597_CR187", "doi-asserted-by": "crossref", "first-page": "1822", "DOI": "10.1172/JCI46110", "volume": "121", "author": "B Savoldo", "year": "2011", "unstructured": "Savoldo, B. et al. CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients. J. Clin. Invest. 121, 1822\u20131826 (2011).", "journal-title": "J. Clin. Invest."}, {"key": "BFnrd4597_CR188", "doi-asserted-by": "crossref", "first-page": "2965", "DOI": "10.1182/blood-2013-06-506741", "volume": "122", "author": "CR Cruz", "year": "2013", "unstructured": "Cruz, C. R. et al. Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study. Blood 122, 2965\u20132973 (2013).", "journal-title": "Blood"}, {"key": "BFnrd4597_CR189", "doi-asserted-by": "crossref", "first-page": "4129", "DOI": "10.1182/blood-2013-08-519413", "volume": "122", "author": "JN Kochenderfer", "year": "2013", "unstructured": "Kochenderfer, J. N. et al. Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation. Blood 122, 4129\u20134139 (2013).", "journal-title": "Blood"}, {"key": "BFnrd4597_CR190", "doi-asserted-by": "crossref", "first-page": "169", "DOI": "10.1097/CJI.0b013e318194a6e8", "volume": "32", "author": "D Hollyman", "year": "2009", "unstructured": "Hollyman, D. et al. Manufacturing validation of biologically functional T cells targeted to CD19 antigen for autologous adoptive cell therapy. J. Immunother. 32, 169\u2013180 (2009).", "journal-title": "J. Immunother."}, {"key": "BFnrd4597_CR191", "doi-asserted-by": "crossref", "first-page": "188", "DOI": "10.1182/blood-2014-05-552729", "volume": "124", "author": "DW Lee", "year": "2014", "unstructured": "Lee, D. W. et al. Current concepts in the diagnosis and management of cytokine release syndrome. Blood 124, 188\u2013195 (2014).", "journal-title": "Blood"}, {"key": "BFnrd4597_CR192", "doi-asserted-by": "crossref", "first-page": "1577", "DOI": "10.4161/onci.22524", "volume": "1", "author": "ML Davila", "year": "2012", "unstructured": "Davila, M. L., Brentjens, R., Wang, X., Riviere, I. & Sadelain, M. How do CARs work? Early insights from recent clinical studies targeting CD19. Oncoimmunology 1, 1577\u20131583 (2012).", "journal-title": "Oncoimmunology"}, {"key": "BFnrd4597_CR193", "doi-asserted-by": "crossref", "first-page": "55ra78", "DOI": "10.1126/scitranslmed.3000448", "volume": "2", "author": "CM Paulos", "year": "2010", "unstructured": "Paulos, C. M. et al. The inducible costimulator (ICOS) is critical for the development of human TH17 cells. Sci. Transl. Med. 2, 55ra78 (2010).", "journal-title": "Sci. Transl. Med."}, {"key": "BFnrd4597_CR194", "doi-asserted-by": "crossref", "first-page": "957", "DOI": "10.1038/ni.2985", "volume": "15", "author": "KJ Oestreich", "year": "2014", "unstructured": "Oestreich, K. J. et al. Bcl-6 directly represses the gene program of the glycolysis pathway. Nat. Immunol. 15, 957\u2013964 (2014).", "journal-title": "Nat. Immunol."}, {"key": "BFnrd4597_CR195", "doi-asserted-by": "crossref", "first-page": "97", "DOI": "10.1038/35051100", "volume": "409", "author": "C Dong", "year": "2001", "unstructured": "Dong, C. et al. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 409, 97\u2013101 (2001).", "journal-title": "Nature"}, {"key": "BFnrd4597_CR196", "doi-asserted-by": "crossref", "first-page": "105", "DOI": "10.1038/35051113", "volume": "409", "author": "A Tafuri", "year": "2001", "unstructured": "Tafuri, A. et al. ICOS is essential for effective T-helper-cell responses. Nature 409, 105\u2013109 (2001).", "journal-title": "Nature"}, {"key": "BFnrd4597_CR197", "doi-asserted-by": "crossref", "first-page": "774", "DOI": "10.4049/jimmunol.180.2.774", "volume": "180", "author": "Y Burmeister", "year": "2008", "unstructured": "Burmeister, Y. et al. ICOS controls the pool size of effector-memory and regulatory T cells. J. Immunol. 180, 774\u2013782 (2008).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR198", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1186/1756-8722-6-33", "volume": "6", "author": "CJ Shen", "year": "2013", "unstructured": "Shen, C. J. et al. Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma. J. Hematol. Oncol. 6, 33 (2013).", "journal-title": "J. Hematol. Oncol."}, {"key": "BFnrd4597_CR199", "doi-asserted-by": "crossref", "first-page": "699", "DOI": "10.1016/S1074-7613(00)80144-2", "volume": "11", "author": "M Kopf", "year": "1999", "unstructured": "Kopf, M. et al. OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL responses after virus infection. Immunity 11, 699\u2013708 (1999).", "journal-title": "Immunity"}, {"key": "BFnrd4597_CR200", "doi-asserted-by": "crossref", "first-page": "7969", "DOI": "10.4049/jimmunol.181.11.7969", "volume": "181", "author": "S Salek-Ardakani", "year": "2008", "unstructured": "Salek-Ardakani, S., Moutaftsi, M., Crotty, S., Sette, A. & Croft, M. OX40 drives protective vaccinia virus-specific CD8 T cells. J. Immunol. 181, 7969\u20137976 (2008).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR201", "doi-asserted-by": "crossref", "first-page": "271", "DOI": "10.1038/nri2526", "volume": "9", "author": "M Croft", "year": "2009", "unstructured": "Croft, M. The role of TNF superfamily members in T-cell function and diseases. Nat. Rev. Immunol. 9, 271\u2013285 (2009).", "journal-title": "Nat. Rev. Immunol."}, {"key": "BFnrd4597_CR202", "doi-asserted-by": "crossref", "first-page": "55", "DOI": "10.1111/j.1600-065X.2011.01055.x", "volume": "244", "author": "JM Hildebrand", "year": "2011", "unstructured": "Hildebrand, J. M. et al. Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions. Immunol. Rev. 244, 55\u201374 (2011).", "journal-title": "Immunol. Rev."}, {"key": "BFnrd4597_CR203", "doi-asserted-by": "crossref", "first-page": "933", "DOI": "10.1016/j.ymthe.2005.04.016", "volume": "12", "author": "MA Pule", "year": "2005", "unstructured": "Pule, M. A. et al. A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells. Mol. Ther. 12, 933\u2013941 (2005).", "journal-title": "Mol. Ther."}, {"key": "BFnrd4597_CR204", "doi-asserted-by": "crossref", "first-page": "4901", "DOI": "10.4049/jimmunol.180.7.4901", "volume": "180", "author": "S Wilkie", "year": "2008", "unstructured": "Wilkie, S. et al. Retargeting of human T cells to tumor-associated MUC1: the evolution of a chimeric antigen receptor. J. Immunol. 180, 4901\u20134909 (2008).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR205", "doi-asserted-by": "crossref", "first-page": "19454", "DOI": "10.1073/pnas.0609706104", "volume": "103", "author": "JM Carr", "year": "2006", "unstructured": "Carr, J. M. et al. CD27 mediates interleukin-2-independent clonal expansion of the CD8+ T cell without effector differentiation. Proc. Natl Acad. Sci. USA 103, 19454\u201319459 (2006).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrd4597_CR206", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.1084/jem.20042020", "volume": "201", "author": "CJ Fox", "year": "2005", "unstructured": "Fox, C. J., Hammerman, P. S. & Thompson, C. B. The Pim kinases control rapamycin-resistant T cell survival and activation. J. Exp. Med. 201, 259\u2013266 (2005).", "journal-title": "J. Exp. Med."}, {"key": "BFnrd4597_CR207", "doi-asserted-by": "crossref", "first-page": "216", "DOI": "10.1111/j.1600-065X.2009.00774.x", "volume": "229", "author": "MA Nolte", "year": "2009", "unstructured": "Nolte, M. A., van Olffen, R. W., van Gisbergen, K. P. & van Lier, R. A. Timing and tuning of CD27\u2013CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology. Immunol. Rev. 229, 216\u2013231 (2009).", "journal-title": "Immunol. Rev."}, {"key": "BFnrd4597_CR208", "doi-asserted-by": "crossref", "first-page": "156", "DOI": "10.1097/PPO.0000000000000029", "volume": "20", "author": "CL Sentman", "year": "2014", "unstructured": "Sentman, C. L. & Meehan, K. R. NKG2D CARs as cell therapy for cancer. Cancer J. 20, 156\u2013159 (2014).", "journal-title": "Cancer J."}, {"key": "BFnrd4597_CR209", "doi-asserted-by": "crossref", "first-page": "1777", "DOI": "10.1158/0008-5472.CAN-12-3558", "volume": "73", "author": "YH Chang", "year": "2013", "unstructured": "Chang, Y. H. et al. A chimeric receptor with NKG2D specificity enhances natural killer cell activation and killing of tumor cells. Cancer Res. 73, 1777\u20131786 (2013).", "journal-title": "Cancer Res."}, {"key": "BFnrd4597_CR210", "doi-asserted-by": "crossref", "first-page": "e31210", "DOI": "10.1371/journal.pone.0031210", "volume": "7", "author": "M Lehner", "year": "2012", "unstructured": "Lehner, M. et al. Redirecting T cells to Ewing's sarcoma family of tumors by a chimeric NKG2D receptor expressed by lentiviral transduction or mRNA transfection. PLoS ONE 7, e31210 (2012).", "journal-title": "PLoS ONE"}, {"key": "BFnrd4597_CR211", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1089/hum.2012.143", "volume": "24", "author": "DG Song", "year": "2013", "unstructured": "Song, D. G. et al. Chimeric NKG2D CAR-expressing T cell-mediated attack of human ovarian cancer is enhanced by histone deacetylase inhibition. Hum. Gene Ther. 24, 295\u2013305 (2013).", "journal-title": "Hum. Gene Ther."}, {"key": "BFnrd4597_CR212", "doi-asserted-by": "crossref", "first-page": "2365", "DOI": "10.4049/jimmunol.0900721", "volume": "183", "author": "A Barber", "year": "2009", "unstructured": "Barber, A. & Sentman, C. L. Chimeric NKG2D T cells require both T cell- and host-derived cytokine secretion and perforin expression to increase tumor antigen presentation and systemic immunity. J. Immunol. 183, 2365\u20132372 (2009).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR213", "doi-asserted-by": "crossref", "first-page": "2455", "DOI": "10.4049/jimmunol.1201314", "volume": "190", "author": "T Zhang", "year": "2013", "unstructured": "Zhang, T. & Sentman, C. L. Mouse tumor vasculature expresses NKG2D ligands and can be targeted by chimeric NKG2D-modified T cells. J. Immunol. 190, 2455\u20132463 (2013).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR214", "doi-asserted-by": "crossref", "first-page": "5563", "DOI": "10.4049/jimmunol.0900447", "volume": "183", "author": "Y Zhao", "year": "2009", "unstructured": "Zhao, Y. et al. A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity. J. Immunol. 183, 5563\u20135574 (2009).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR215", "doi-asserted-by": "crossref", "first-page": "712", "DOI": "10.1089/hum.2007.028", "volume": "18", "author": "J Wang", "year": "2007", "unstructured": "Wang, J. et al. Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domains. Hum. Gene Ther. 18, 712\u2013725 (2007).", "journal-title": "Hum. Gene Ther."}, {"key": "BFnrd4597_CR216", "doi-asserted-by": "crossref", "first-page": "3940", "DOI": "10.1182/blood-2011-10-387969", "volume": "119", "author": "BG Till", "year": "2012", "unstructured": "Till, B. G. et al. CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results. Blood 119, 3940\u20133950 (2012).", "journal-title": "Blood"}, {"key": "BFnrd4597_CR217", "doi-asserted-by": "crossref", "first-page": "843", "DOI": "10.1038/mt.2010.24", "volume": "18", "author": "RA Morgan", "year": "2010", "unstructured": "Morgan, R. A. et al. Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2. Mol. Ther. 18, 843\u2013851 (2010).", "journal-title": "Mol. Ther."}, {"key": "BFnrd4597_CR218", "doi-asserted-by": "crossref", "first-page": "71", "DOI": "10.1038/nbt.2459", "volume": "31", "author": "CC Kloss", "year": "2013", "unstructured": "Kloss, C. C., Condomines, M., Cartellieri, M., Bachmann, M. & Sadelain, M. Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells. Nat. Biotechnol. 31, 71\u201375 (2013).", "journal-title": "Nat. Biotechnol."}, {"key": "BFnrd4597_CR219", "doi-asserted-by": "crossref", "first-page": "1059", "DOI": "10.1007/s10875-012-9689-9", "volume": "32", "author": "S Wilkie", "year": "2012", "unstructured": "Wilkie, S. et al. Dual targeting of ErbB2 and MUC1 in breast cancer using chimeric antigen receptors engineered to provide complementary signaling. J. Clin. Immunol. 32, 1059\u20131070 (2012).", "journal-title": "J. Clin. Immunol."}, {"key": "BFnrd4597_CR220", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1158/2326-6066.CIR-13-0008", "volume": "1", "author": "E Lanitis", "year": "2013", "unstructured": "Lanitis, E. et al. Chimeric antigen receptor T cells with dissociated signaling domains exhibit focused antitumor activity with reduced potential for toxicity in vivo. Cancer Immunol. Res. 1, 43\u201353 (2013).", "journal-title": "Cancer Immunol. Res."}, {"key": "BFnrd4597_CR221", "doi-asserted-by": "crossref", "first-page": "3153", "DOI": "10.1158/1078-0432.CCR-13-0330", "volume": "19", "author": "M Hudecek", "year": "2013", "unstructured": "Hudecek, M. et al. Receptor affinity and extracellular domain modifications affect tumor recognition by ROR1-specific chimeric antigen receptor T cells Clin. Cancer Res. 19, 3153\u20133164 (2013).", "journal-title": "Clin. Cancer Res."}, {"key": "BFnrd4597_CR222", "doi-asserted-by": "crossref", "first-page": "125", "DOI": "10.1158/2326-6066.CIR-14-0127", "volume": "3", "author": "M Hudecek", "year": "2015", "unstructured": "Hudecek, M. et al. The nonsignaling extracellular spacer domain of chimeric antigen receptors is decisive for in vivo antitumor activity. Cancer Immunol. Res. 3, 125\u2013135 (2015).", "journal-title": "Cancer Immunol. Res."}, {"key": "BFnrd4597_CR223", "doi-asserted-by": "crossref", "first-page": "7028", "DOI": "10.4049/jimmunol.180.10.7028", "volume": "180", "author": "SE James", "year": "2008", "unstructured": "James, S. E. et al. Antigen sensitivity of CD22-specific chimeric TCR is modulated by target epitope distance from the cell membrane. J. Immunol. 180, 7028\u20137038 (2008).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR224", "doi-asserted-by": "crossref", "first-page": "203", "DOI": "10.1097/01.cji.0000161397.96582.59", "volume": "28", "author": "RD Guest", "year": "2005", "unstructured": "Guest, R. D. et al. The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigens. J. Immunother. 28, 203\u2013211 (2005).", "journal-title": "J. Immunother."}, {"key": "BFnrd4597_CR225", "doi-asserted-by": "crossref", "first-page": "391", "DOI": "10.1038/gt.2015.4", "volume": "22", "author": "H Almasbak", "year": "2015", "unstructured": "Almasbak, H. et al. Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model. Gene Ther. 22, 391\u2013403 (2015).", "journal-title": "Gene Ther."}, {"key": "BFnrd4597_CR226", "first-page": "145", "volume": "160", "author": "CJ Fitzer-Attas", "year": "1998", "unstructured": "Fitzer-Attas, C. J., Schindler, D. G., Waks, T. & Eshhar, Z. Harnessing Syk family tyrosine kinases as signaling domains for chimeric single chain of the variable domain receptors: optimal design for T cell activation. J. Immunol. 160, 145\u2013154 (1998).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR227", "doi-asserted-by": "crossref", "first-page": "6938", "DOI": "10.4049/jimmunol.0901766", "volume": "184", "author": "JS Bridgeman", "year": "2010", "unstructured": "Bridgeman, J. S. et al. The optimal antigen response of chimeric antigen receptors harboring the CD3\u03b6 transmembrane domain is dependent upon incorporation of the receptor into the endogenous TCR/CD3 complex. J. Immunol. 184, 6938\u20136949 (2010).", "journal-title": "J. Immunol."}, {"key": "BFnrd4597_CR228", "doi-asserted-by": "crossref", "first-page": "439", "DOI": "10.1016/j.ccell.2015.03.007", "volume": "27", "author": "JF Miller", "year": "2015", "unstructured": "Miller, J. F. & Sadelain, M. The journey from discoveries in fundamental immunology to cancer immunotherapy. Cancer Cell 27, 439\u2013449 (2015).", "journal-title": "Cancer Cell"}, {"key": "BFnrd4597_CR229", "doi-asserted-by": "crossref", "first-page": "1018", "DOI": "10.1056/NEJMoa063842", "volume": "355", "author": "G Suntharalingam", "year": "2006", "unstructured": "Suntharalingam, G. et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N. Engl. J. Med. 355, 1018\u20131028 (2006).", "journal-title": "N. Engl. J. Med."}, {"key": "BFnrd4597_CR230", "doi-asserted-by": "crossref", "first-page": "1044", "DOI": "10.1158/1078-0432.CCR-12-2065", "volume": "19", "author": "I Melero", "year": "2013", "unstructured": "Melero, I., Hirschhorn-Cymerman, D., Morales-Kastresana, A., Sanmamed, M. F. & Wolchok, J. D. Agonist antibodies to TNFR molecules that costimulate T and NK cells. Clin. Cancer Res. 19, 1044\u20131053 (2013).", "journal-title": "Clin. Cancer Res."}, {"key": "BFnrd4597_CR231", "doi-asserted-by": "crossref", "first-page": "130", "DOI": "10.1038/nrd3877", "volume": "12", "author": "S Yao", "year": "2013", "unstructured": "Yao, S., Zhu, Y. & Chen, L. Advances in targeting cell surface signalling molecules for immune modulation. Nat. Rev. Drug Discov. 12, 130\u2013146 (2013).", "journal-title": "Nat. Rev. Drug Discov."}, {"key": "BFnrd4597_CR232", "doi-asserted-by": "crossref", "first-page": "91", "DOI": "10.1038/nrclinonc.2013.245", "volume": "11", "author": "TC Gangadhar", "year": "2014", "unstructured": "Gangadhar, T. C. & Vonderheide, R. H. Mitigating the toxic effects of anticancer immunotherapy. Nat. Rev. Clin. Oncol. 11, 91\u201399 (2014).", "journal-title": "Nat. Rev. Clin. Oncol."}, {"key": "BFnrd4597_CR233", "doi-asserted-by": "crossref", "first-page": "7189", "DOI": "10.1158/0008-5472.CAN-12-4174", "volume": "73", "author": "BD Curti", "year": "2013", "unstructured": "Curti, B. D. et al. OX40 is a potent immune-stimulating target in late-stage cancer patients. Cancer Res. 73, 7189\u20137198 (2013).", "journal-title": "Cancer Res."}, {"key": "BFnrd4597_CR234", "doi-asserted-by": "crossref", "first-page": "44", "DOI": "10.1186/1756-8722-7-44", "volume": "7", "author": "S de Vos", "year": "2014", "unstructured": "de Vos, S. et al. A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors. J. Hematol. Oncol. 7, 44 (2014).", "journal-title": "J. Hematol. Oncol."}, {"key": "BFnrd4597_CR235", "doi-asserted-by": "crossref", "first-page": "845", "DOI": "10.3324/haematol.2009.008003", "volume": "95", "author": "M Hussein", "year": "2010", "unstructured": "Hussein, M. et al. A phase I multidose study of dacetuzumab (SGN-40; humanized anti-CD40 monoclonal antibody) in patients with multiple myeloma. Haematologica 95, 845\u2013848 (2010).", "journal-title": "Haematologica"}, {"key": "BFnrd4597_CR236", "doi-asserted-by": "crossref", "first-page": "228", "DOI": "10.3109/10428190903440946", "volume": "51", "author": "RR Furman", "year": "2010", "unstructured": "Furman, R. R., Forero-Torres, A., Shustov, A. & Drachman, J. G. A Phase I study of dacetuzumab (SGN-40, a humanized anti-CD40 monoclonal antibody) in patients with chronic lymphocytic leukemia. Leuk. Lymphoma 51, 228\u2013235 (2010).", "journal-title": "Leuk. Lymphoma"}, {"key": "BFnrd4597_CR237", "doi-asserted-by": "crossref", "first-page": "4371", "DOI": "10.1200/JCO.2008.21.3017", "volume": "27", "author": "R Advani", "year": "2009", "unstructured": "Advani, R. et al. Phase I study of the humanized anti-CD40 monoclonal antibody dacetuzumab in refractory or recurrent non-Hodgkin's lymphoma. J. Clin. Oncol. 27, 4371\u20134377 (2009).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrd4597_CR238", "doi-asserted-by": "crossref", "first-page": "1020", "DOI": "10.1200/JCO.2013.53.0105", "volume": "32", "author": "SL Topalian", "year": "2014", "unstructured": "Topalian, S. L. et al. Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab. J. Clin. Oncol. 32, 1020\u20131030 (2014).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrd4597_CR239", "doi-asserted-by": "crossref", "first-page": "711", "DOI": "10.1056/NEJMoa1003466", "volume": "363", "author": "FS Hodi", "year": "2010", "unstructured": "Hodi, F. S. et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363, 711\u2013723 (2010).", "journal-title": "N. Engl. J. Med."}, {"key": "BFnrd4597_CR240", "doi-asserted-by": "crossref", "first-page": "2455", "DOI": "10.1056/NEJMoa1200694", "volume": "366", "author": "JR Brahmer", "year": "2012", "unstructured": "Brahmer, J. R. et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N. Engl. J. Med. 366, 2455\u20132465 (2012).", "journal-title": "N. Engl. J. Med."}, {"key": "BFnrd4597_CR241", "doi-asserted-by": "crossref", "first-page": "1744", "DOI": "10.1001/jama.2014.13943", "volume": "312", "author": "FS Hodi", "year": "2014", "unstructured": "Hodi, F. S. et al. Ipilimumab plus sargramostim versus ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial. JAMA 312, 1744\u20131753 (2014).", "journal-title": "JAMA"}, {"key": "BFnrd4597_CR242", "doi-asserted-by": "crossref", "first-page": "2443", "DOI": "10.1056/NEJMoa1200690", "volume": "366", "author": "SL Topalian", "year": "2012", "unstructured": "Topalian, S. L. et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 366, 2443\u20132454 (2012).", "journal-title": "N. Engl. J. Med."}], "container-title": ["Nature Reviews Drug Discovery"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/nrd4597.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/nrd4597", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/nrd4597.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 30]], "date-time": "2019-09-30T21:17:02Z", "timestamp": 1569878222000}, "score": 36.378216, "issued": {"date-parts": [[2015, 7]]}, "references-count": 242, "journal-issue": {"published-print": {"date-parts": [[2015, 7]]}, "issue": "7"}, "alternative-id": ["BFnrd4597"], "URL": "http://dx.doi.org/10.1038/nrd4597", "relation": {"cites": []}, "ISSN": ["1474-1776", "1474-1784"], "issn-type": [{"value": "1474-1776", "type": "print"}, {"value": "1474-1784", "type": "electronic"}], "assertion": [{"value": "1 July 2015", "order": 1, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "M.S. is scientific co-founder of Juno Therapeutics. All other authors declare no conflict of interest.", "order": 1, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Competing interests"}}]}, {"indexed": {"date-parts": [[2019, 12, 18]], "date-time": "2019-12-18T01:03:19Z", "timestamp": 1576630999377}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Discovery"], "published-print": {"date-parts": [[2013, 4]]}, "DOI": "10.1158/2159-8290.cd-12-0548", "type": "journal-article", "created": {"date-parts": [[2013, 4, 3]], "date-time": "2013-04-03T02:37:27Z", "timestamp": 1364956647000}, "page": "388-398", "source": "Crossref", "is-referenced-by-count": 427, "title": ["The Basic Principles of Chimeric Antigen Receptor Design"], "prefix": "10.1158", "volume": "3", "author": [{"given": "Michel", "family": "Sadelain", "sequence": "first", "affiliation": []}, {"given": "Renier", "family": "Brentjens", "sequence": "additional", "affiliation": []}, {"given": "Isabelle", "family": "Rivi\u00e8re", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2013, 4, 2]]}, "container-title": ["Cancer Discovery"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/2159-8290.CD-12-0548", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 1, 11]], "date-time": "2017-01-11T20:15:32Z", "timestamp": 1484165732000}, "score": 35.619564, "issued": {"date-parts": [[2013, 4]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2013, 4, 10]]}, "published-print": {"date-parts": [[2013, 4]]}, "issue": "4"}, "alternative-id": ["10.1158/2159-8290.CD-12-0548"], "URL": "http://dx.doi.org/10.1158/2159-8290.cd-12-0548", "ISSN": ["2159-8274", "2159-8290"], "issn-type": [{"value": "2159-8274", "type": "print"}, {"value": "2159-8290", "type": "electronic"}], "subject": ["Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T08:14:55Z", "timestamp": 1574496895815}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2010, 4, 15]]}, "DOI": "10.1158/1538-7445.am10-1944", "type": "proceedings-article", "created": {"date-parts": [[2011, 2, 25]], "date-time": "2011-02-25T18:19:10Z", "timestamp": 1298657950000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract 1944:In vitroanalysis of suicide gene expression and function in human T lymphocytes transduced to express a tumor targeted chimeric antigen receptor"], "prefix": "10.1158", "author": [{"given": "Jae", "family": "Park", "sequence": "first", "affiliation": []}, {"given": "Raymond", "family": "Yeh", "sequence": "additional", "affiliation": []}, {"given": "Isabelle", "family": "Riviere", "sequence": "additional", "affiliation": []}, {"given": "Michel", "family": "Sadelain", "sequence": "additional", "affiliation": []}, {"given": "Renier", "family": "Brentjens", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 11, 17]]}, "event": {"name": "Proceedings: AACR 101st Annual Meeting 2010\u2010\u2010 Apr 17\u201021, 2010; Washington, DC"}, "container-title": ["Immunology"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.AM10-1944", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T17:11:12Z", "timestamp": 1558199472000}, "score": 35.50105, "issued": {"date-parts": [[2010, 4, 15]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.AM10-1944"], "URL": "http://dx.doi.org/10.1158/1538-7445.am10-1944"}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T18:31:41Z", "timestamp": 1574706701217}, "reference-count": 51, "publisher": "Public Library of Science (PLoS)", "issue": "6", "license": [{"URL": "http://creativecommons.org/licenses/by/4.0/", "start": {"date-parts": [[2015, 6, 25]], "date-time": "2015-06-25T00:00:00Z", "timestamp": 1435190400000}, "delay-in-days": 0, "content-version": "vor"}], "content-domain": {"domain": ["www.plosone.org"], "crossmark-restriction": false}, "short-container-title": ["PLoS ONE"], "DOI": "10.1371/journal.pone.0130518", "type": "journal-article", "created": {"date-parts": [[2015, 6, 25]], "date-time": "2015-06-25T18:20:29Z", "timestamp": 1435256429000}, "page": "e0130518", "update-policy": "http://dx.doi.org/10.1371/journal.pone.corrections_policy", "source": "Crossref", "is-referenced-by-count": 21, "title": ["Tumor-Targeted Human T Cells Expressing CD28-Based Chimeric Antigen Receptors Circumvent CTLA-4 Inhibition"], "prefix": "10.1371", "volume": "10", "author": [{"given": "Maud", "family": "Condomines", "sequence": "first", "affiliation": []}, {"given": "Jon", "family": "Arnason", "sequence": "additional", "affiliation": []}, {"given": "Reuben", "family": "Benjamin", "sequence": "additional", "affiliation": []}, {"given": "Gertrude", "family": "Gunset", "sequence": "additional", "affiliation": []}, {"given": "Jason", "family": "Plotkin", "sequence": "additional", "affiliation": []}, {"given": "Michel", "family": "Sadelain", "sequence": "additional", "affiliation": []}], "member": "340", "published-online": {"date-parts": [[2015, 6, 25]]}, "reference": [{"key": "ref1", "doi-asserted-by": "crossref", "first-page": "917", "DOI": "10.1200/JCO.2010.32.2537", "article-title": "Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1", "volume": "29", "author": "PF Robbins", "year": "2011", "journal-title": "J Clin Oncol"}, {"key": "ref2", "doi-asserted-by": "crossref", "first-page": "725", "DOI": "10.1056/NEJMoa1103849", "article-title": "Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia", "volume": "365", "author": "DL Porter", "year": "2011", "journal-title": "N Engl J Med"}, {"key": "ref3", "doi-asserted-by": "crossref", "first-page": "2709", "DOI": "10.1182/blood-2011-10-384388", "article-title": "B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells", "volume": "119", "author": "JN Kochenderfer", "year": "2012", "journal-title": "Blood"}, {"key": "ref4", "doi-asserted-by": "crossref", "first-page": "177ra138", "DOI": "10.1126/scitranslmed.3005930", "article-title": "CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia", "volume": "5", "author": "RJ Brentjens", "year": "2013", "journal-title": "Sci Transl Med"}, {"key": "ref5", "doi-asserted-by": "crossref", "first-page": "224ra225", "DOI": "10.1126/scitranslmed.3008226", "article-title": "Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia", "volume": "6", "author": "ML Davila", "year": "2014", "journal-title": "Sci Transl Med"}, {"key": "ref6", "doi-asserted-by": "crossref", "first-page": "279", "DOI": "10.1038/nm827", "article-title": "Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15", "volume": "9", "author": "RJ Brentjens", "year": "2003", "journal-title": "Nat Med"}, {"key": "ref7", "doi-asserted-by": "crossref", "first-page": "432", "DOI": "10.1038/mt.2011.1", "article-title": "CARs on track in the clinic", "volume": "19", "author": "DB Kohn", "year": "2011", "journal-title": "Mol Ther"}, {"key": "ref8", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1038/nrc971", "article-title": "Targeting tumours with genetically enhanced T lymphocytes", "volume": "3", "author": "M Sadelain", "year": "2003", "journal-title": "Nat Rev Cancer"}, {"key": "ref9", "doi-asserted-by": "crossref", "first-page": "3370", "DOI": "10.1096/fasebj.6.15.1464371", "article-title": "Endowing T cells with antibody specificity using chimeric T cell receptors", "volume": "6", "author": "G Gross", "year": "1992", "journal-title": "FASEB J"}, {"key": "ref10", "doi-asserted-by": "crossref", "first-page": "123", "DOI": "10.1038/sj.neo.7900018", "article-title": "Cancer patient T cells genetically targeted to prostate-specific membrane antigen specifically lyse prostate cancer cells and release cytokines in response to prostate-specific membrane antigen", "volume": "1", "author": "MC Gong", "year": "1999", "journal-title": "Neoplasia"}, {"key": "ref11", "first-page": "1999", "article-title": "Chimeric Fv-zeta or Fv-epsilon receptors are not sufficient to induce activation or cytokine production in peripheral T cells", "volume": "96", "author": "T Brocker", "year": "2000", "journal-title": "Blood"}, {"key": "ref12", "doi-asserted-by": "crossref", "first-page": "1822", "DOI": "10.1172/JCI46110", "article-title": "CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients", "volume": "121", "author": "B Savoldo", "year": "2011", "journal-title": "J Clin Invest"}, {"key": "ref13", "doi-asserted-by": "crossref", "first-page": "70", "DOI": "10.1038/nbt0102-70", "article-title": "Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta /CD28 receptor", "volume": "20", "author": "J Maher", "year": "2002", "journal-title": "Nat Biotechnol"}, {"key": "ref14", "doi-asserted-by": "crossref", "first-page": "10995", "DOI": "10.1158/0008-5472.CAN-06-0160", "article-title": "CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells", "volume": "66", "author": "CM Kowolik", "year": "2006", "journal-title": "Cancer Res"}, {"key": "ref15", "doi-asserted-by": "crossref", "first-page": "1440", "DOI": "10.1038/nm1676", "article-title": "T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection", "volume": "13", "author": "MT Stephan", "year": "2007", "journal-title": "Nat Med"}, {"key": "ref16", "doi-asserted-by": "crossref", "first-page": "3360", "DOI": "10.1073/pnas.0813101106", "article-title": "Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains", "volume": "106", "author": "C Carpenito", "year": "2009", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "ref17", "doi-asserted-by": "crossref", "first-page": "413", "DOI": "10.1038/mt.2009.210", "article-title": "Chimeric antigen receptors combining 4-1BB and CD28 signaling domains augment PI3kinase/AKT/Bcl-XL activation and CD8+ T cell-mediated tumor eradication", "volume": "18", "author": "XS Zhong", "year": "2010", "journal-title": "Mol Ther"}, {"key": "ref18", "doi-asserted-by": "crossref", "first-page": "104", "DOI": "10.4049/jimmunol.172.1.104", "article-title": "Activation of resting human primary T cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain", "volume": "172", "author": "HM Finney", "year": "2004", "journal-title": "J Immunol"}, {"key": "ref19", "doi-asserted-by": "crossref", "first-page": "5426", "DOI": "10.1158/1078-0432.CCR-07-0674", "article-title": "Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts", "volume": "13", "author": "RJ Brentjens", "year": "2007", "journal-title": "Clin Cancer Res"}, {"key": "ref20", "doi-asserted-by": "crossref", "first-page": "12", "DOI": "10.1111/j.1600-065X.2009.00770.x", "article-title": "CD28 and CTLA-4 coreceptor expression and signal transduction", "volume": "229", "author": "CE Rudd", "year": "2009", "journal-title": "Immunol Rev"}, {"key": "ref21", "doi-asserted-by": "crossref", "first-page": "23", "DOI": "10.1016/S1074-7613(01)00259-X", "article-title": "Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength", "volume": "16", "author": "JG Egen", "year": "2002", "journal-title": "Immunity"}, {"key": "ref22", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.1146/annurev.immunol.24.021605.090535", "article-title": "A molecular perspective of CTLA-4 function", "volume": "24", "author": "WA Teft", "year": "2006", "journal-title": "Annu Rev Immunol"}, {"key": "ref23", "doi-asserted-by": "crossref", "first-page": "608", "DOI": "10.1038/35069118", "article-title": "Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses", "volume": "410", "author": "CC Stamper", "year": "2001", "journal-title": "Nature"}, {"key": "ref24", "doi-asserted-by": "crossref", "first-page": "1675", "DOI": "10.1084/jem.194.11.1675", "article-title": "Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function", "volume": "194", "author": "M Martin", "year": "2001", "journal-title": "J Exp Med"}, {"key": "ref25", "doi-asserted-by": "crossref", "first-page": "129", "DOI": "10.1084/jem.20021646", "article-title": "Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-associated antigen 4", "volume": "197", "author": "S Chikuma", "year": "2003", "journal-title": "J Exp Med"}, {"key": "ref26", "doi-asserted-by": "crossref", "first-page": "1972", "DOI": "10.1126/science.1131078", "article-title": "Reversal of the TCR stop signal by CTLA-4", "volume": "313", "author": "H Schneider", "year": "2006", "journal-title": "Science"}, {"key": "ref27", "doi-asserted-by": "crossref", "first-page": "600", "DOI": "10.1126/science.1202947", "article-title": "Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4", "volume": "332", "author": "OS Qureshi", "year": "2011", "journal-title": "Science"}, {"key": "ref28", "doi-asserted-by": "crossref", "first-page": "326", "DOI": "10.1016/j.immuni.2010.09.006", "article-title": "Spatiotemporal basis of CTLA-4 costimulatory molecule-mediated negative regulation of T cell activation", "volume": "33", "author": "T Yokosuka", "year": "2010", "journal-title": "Immunity"}, {"key": "ref29", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1016/j.it.2014.12.001", "article-title": "Confusing signals: recent progress in CTLA-4 biology", "volume": "36", "author": "LS Walker", "year": "2015", "journal-title": "Trends Immunol"}, {"key": "ref30", "doi-asserted-by": "crossref", "first-page": "5319", "DOI": "10.4049/jimmunol.164.10.5319", "article-title": "Structural analysis of CTLA-4 function in vivo", "volume": "164", "author": "EL Masteller", "year": "2000", "journal-title": "J Immunol"}, {"key": "ref31", "doi-asserted-by": "crossref", "first-page": "1737", "DOI": "10.1002/eji.201343891", "article-title": "Tyrosine 201 of the cytoplasmic tail of CTLA-4 critically affects T regulatory cell suppressive function", "volume": "44", "author": "M Stumpf", "year": "2014", "journal-title": "Eur J Immunol"}, {"key": "ref32", "doi-asserted-by": "crossref", "first-page": "3508", "DOI": "10.1182/blood-2009-09-241398", "article-title": "IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice", "volume": "115", "author": "JC Markley", "year": "2010", "journal-title": "Blood"}, {"key": "ref33", "first-page": "952", "article-title": "Recombinant retroviruses pseudotyped with the vesicular stomatitis virus G glycoprotein mediate both stable gene transfer and pseudotransduction in human peripheral blood lymphocytes", "volume": "90", "author": "HF Gallardo", "year": "1997", "journal-title": "Blood"}, {"key": "ref34", "doi-asserted-by": "crossref", "first-page": "966", "DOI": "10.1089/hum.2009.001", "article-title": "Efficient human hematopoietic cell transduction using RD114- and GALV-pseudotyped retroviral vectors produced in suspension and serum-free media", "volume": "20", "author": "K Ghani", "year": "2009", "journal-title": "Hum Gene Ther"}, {"key": "ref35", "doi-asserted-by": "crossref", "first-page": "9080", "DOI": "10.1158/0008-5472.CAN-05-0436", "article-title": "Targeted elimination of prostate cancer by genetically directed human T lymphocytes", "volume": "65", "author": "TP Gade", "year": "2005", "journal-title": "Cancer Res"}, {"key": "ref36", "doi-asserted-by": "crossref", "first-page": "996", "DOI": "10.4049/jimmunol.175.2.996", "article-title": "Hierarchical regulation of CTLA-4 dimer-based lattice formation and its biological relevance for T cell inactivation", "volume": "175", "author": "PJ Darlington", "year": "2005", "journal-title": "J Immunol"}, {"key": "ref37", "doi-asserted-by": "crossref", "first-page": "1118", "DOI": "10.4049/jimmunol.1200972", "article-title": "Cutting edge: cell-extrinsic immune regulation by ctla-4 expressed on conventional T cells", "volume": "189", "author": "CJ Wang", "year": "2012", "journal-title": "J Immunol"}, {"key": "ref38", "doi-asserted-by": "crossref", "first-page": "1123", "DOI": "10.4049/jimmunol.1200695", "article-title": "Cutting edge: ctla-4 on effector T cells inhibits in trans", "volume": "189", "author": "E Corse", "year": "2012", "journal-title": "J Immunol"}, {"key": "ref39", "doi-asserted-by": "crossref", "first-page": "2699", "DOI": "10.1002/eji.201141428", "article-title": "Regulation of antigen-expressing dendritic cells by double negative regulatory T cells", "volume": "41", "author": "JF Gao", "year": "2011", "journal-title": "Eur J Immunol"}, {"key": "ref40", "doi-asserted-by": "crossref", "first-page": "1143", "DOI": "10.1002/eji.201343601", "article-title": "Cell-extrinsic CTLA4-mediated regulation of dendritic cell maturation depends on STAT3", "volume": "44", "author": "A Kowalczyk", "year": "2014", "journal-title": "Eur J Immunol"}, {"key": "ref41", "doi-asserted-by": "crossref", "first-page": "1013", "DOI": "10.1016/j.immuni.2014.12.006", "article-title": "Regulatory T cells control antigen-specific expansion of Tfh cell number and humoral immune responses via the coreceptor CTLA-4", "volume": "41", "author": "JB Wing", "year": "2014", "journal-title": "Immunity"}, {"key": "ref42", "doi-asserted-by": "crossref", "first-page": "465", "DOI": "10.1038/ni.2866", "article-title": "Protein kinase C-eta controls CTLA-4-mediated regulatory T cell function", "volume": "15", "author": "KF Kong", "year": "2014", "journal-title": "Nat Immunol"}, {"key": "ref43", "doi-asserted-by": "crossref", "first-page": "637", "DOI": "10.1084/jem.20091918", "article-title": "Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts", "volume": "207", "author": "SA Quezada", "year": "2010", "journal-title": "J Exp Med"}, {"key": "ref44", "doi-asserted-by": "crossref", "first-page": "20410", "DOI": "10.1073/pnas.0810114105", "article-title": "CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit", "volume": "105", "author": "J Yuan", "year": "2008", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "ref45", "doi-asserted-by": "crossref", "first-page": "155", "DOI": "10.1016/S1470-2045(09)70334-1", "article-title": "Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study", "volume": "11", "author": "JD Wolchok", "year": "2010", "journal-title": "Lancet Oncol"}, {"key": "ref46", "doi-asserted-by": "crossref", "first-page": "254ra128", "DOI": "10.1126/scitranslmed.3008918", "article-title": "Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response", "volume": "6", "author": "P Kvistborg", "year": "2014", "journal-title": "Sci Transl Med"}, {"key": "ref47", "doi-asserted-by": "crossref", "first-page": "80ra34", "DOI": "10.1126/scitranslmed.3002207", "article-title": "Establishment of antitumor memory in humans using in vitro-educated CD8+ T cells", "volume": "3", "author": "MO Butler", "year": "2011", "journal-title": "Sci Transl Med"}, {"key": "ref48", "doi-asserted-by": "crossref", "first-page": "711", "DOI": "10.1056/NEJMoa1003466", "article-title": "Improved survival with ipilimumab in patients with metastatic melanoma", "volume": "363", "author": "FS Hodi", "year": "2010", "journal-title": "New England Journal of Medicine"}, {"key": "ref49", "doi-asserted-by": "crossref", "first-page": "2189", "DOI": "10.1056/NEJMoa1406498", "article-title": "Genetic basis for clinical response to CTLA-4 blockade in melanoma", "volume": "371", "author": "A Snyder", "year": "2014", "journal-title": "N Engl J Med"}, {"key": "ref50", "doi-asserted-by": "crossref", "first-page": "2691", "DOI": "10.1200/JCO.2012.41.6750", "article-title": "Management of immune-related adverse events and kinetics of response with ipilimumab", "volume": "30", "author": "JS Weber", "year": "2012", "journal-title": "J Clin Oncol"}, {"key": "ref51", "doi-asserted-by": "crossref", "first-page": "807", "DOI": "10.1038/nm.2700", "article-title": "Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer", "volume": "18", "author": "E Provasi", "year": "2012", "journal-title": "Nature Medicine"}], "container-title": ["PLOS ONE"], "language": "en", "link": [{"URL": "http://dx.plos.org/10.1371/journal.pone.0130518", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 8, 27]], "date-time": "2019-08-27T18:31:19Z", "timestamp": 1566930679000}, "score": 32.980747, "editor": [{"given": "Ryan M.", "family": "Teague", "sequence": "first", "affiliation": []}], "issued": {"date-parts": [[2015, 6, 25]]}, "references-count": 51, "journal-issue": {"published-online": {"date-parts": [[2015, 6, 25]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.1371/journal.pone.0130518", "relation": {"cites": []}, "ISSN": ["1932-6203"], "issn-type": [{"value": "1932-6203", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T22:21:34Z", "timestamp": 1575411694346}, "reference-count": 56, "publisher": "American Association for the Advancement of Science (AAAS)", "issue": "215", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Science Translational Medicine"], "published-print": {"date-parts": [[2013, 12, 11]]}, "DOI": "10.1126/scitranslmed.3006597", "type": "journal-article", "created": {"date-parts": [[2013, 12, 11]], "date-time": "2013-12-11T21:18:44Z", "timestamp": 1386796724000}, "page": "215ra172-215ra172", "source": "Crossref", "is-referenced-by-count": 230, "title": ["PD-1- and CTLA-4-Based Inhibitory Chimeric Antigen Receptors (iCARs) Divert Off-Target Immunotherapy Responses"], "prefix": "10.1126", "volume": "5", "author": [{"given": "V. D.", "family": "Fedorov", "sequence": "first", "affiliation": []}, {"given": "M.", "family": "Themeli", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Sadelain", "sequence": "additional", "affiliation": []}], "member": "221", "published-online": {"date-parts": [[2013, 12, 11]]}, "reference": [{"issue": "5681", "key": "1_18257618", "doi-asserted-by": "publisher", "first-page": "200", "DOI": "10.1126/science.1100369", "volume": "305", "author": "Blattman", "year": "2004", "journal-title": "Science", "ISSN": "http://id.crossref.org/issn/0036-8075", "issn-type": "print"}, {"issue": "4", "key": "2_42218305", "doi-asserted-by": "publisher", "first-page": "269", "DOI": "10.1038/nri3191", "volume": "12", "author": "Restifo", "year": "2012", "journal-title": "Nature reviews. Immunology", "ISSN": "http://id.crossref.org/issn/1474-1733", "issn-type": "print"}, {"issue": "2", "key": "3_34485834", "doi-asserted-by": "publisher", "first-page": "215", "DOI": "10.1016/j.coi.2009.02.009", "volume": "21", "author": "Sadelain", "year": "2009", "journal-title": "Current opinion in immunology", "ISSN": "http://id.crossref.org/issn/0952-7915", "issn-type": "print"}, {"issue": "5", "key": "4_43273765", "doi-asserted-by": "publisher", "first-page": "633", "DOI": "10.1016/j.coi.2012.06.004", "volume": "24", "author": "Turtle", "year": "2012", "journal-title": "Current opinion in immunology", "ISSN": "http://id.crossref.org/issn/0952-7915", "issn-type": "print"}, {"issue": "6", "key": "5_42572593", "doi-asserted-by": "publisher", "first-page": "443", "DOI": "10.1038/nri3212", "volume": "12", "author": "Blazar", "year": "2012", "journal-title": "Nature reviews. Immunology", "ISSN": "http://id.crossref.org/issn/1474-1733", "issn-type": "print"}, {"key": "6_31517443", "doi-asserted-by": "publisher", "first-page": "371", "DOI": "10.1111/j.1600-065X.2008.00637.x", "volume": "223", "author": "Brusko", "year": "2008", "journal-title": "Immunological reviews", "ISSN": "http://id.crossref.org/issn/0105-2896", "issn-type": "print"}, {"issue": "95", "key": "7_40522347", "doi-asserted-by": "publisher", "first-page": "95ra73", "DOI": "10.1126/scitranslmed.3002842", "volume": "3", "author": "Kalos", "year": "2011", "journal-title": "Science Translational Medicine", "ISSN": "http://id.crossref.org/issn/1946-6234", "issn-type": "print"}, {"issue": "18", "key": "8_40582039", "doi-asserted-by": "publisher", "first-page": "4817", "DOI": "10.1182/blood-2011-04-348540", "volume": "118", "year": "2011", "journal-title": "Blood", "ISSN": "http://id.crossref.org/issn/0006-4971", "issn-type": "print"}, {"issue": "177", "key": "9_45471740", "doi-asserted-by": "publisher", "first-page": "177ra38", "DOI": "10.1126/scitranslmed.3005930", "volume": "5", "author": "Brentjens", "year": "2013", "journal-title": "Science Translational Medicine", "ISSN": "http://id.crossref.org/issn/1946-6234", "issn-type": "print"}, {"issue": "4", "key": "10_36702240", "doi-asserted-by": "publisher", "first-page": "843", "DOI": "10.1038/mt.2010.24", "volume": "18", "author": "Morgan", "year": "2010", "journal-title": "Molecular therapy : the journal of the American Society of Gene Therapy", "ISSN": "http://id.crossref.org/issn/1525-0016", "issn-type": "print"}, {"key": "11_45581892", "ISSN": "http://id.crossref.org/issn/1750-7448", "issn-type": "print", "volume": "36", "first-page": "133", "year": "2013"}, {"issue": "197", "key": "12_46278208", "doi-asserted-by": "publisher", "first-page": "197ra103", "DOI": "10.1126/scitranslmed.3006034", "volume": "5", "author": "Cameron", "year": "2013", "journal-title": "Science Translational Medicine", "ISSN": "http://id.crossref.org/issn/1946-6234", "issn-type": "print"}, {"issue": "6", "key": "13_46000054", "doi-asserted-by": "publisher", "first-page": "863", "DOI": "10.1182/blood-2013-03-490565", "volume": "122", "year": "2013", "journal-title": "Blood", "ISSN": "http://id.crossref.org/issn/0006-4971", "issn-type": "print"}, {"issue": "9674", "key": "14_34312156", "doi-asserted-by": "publisher", "first-page": "1550", "DOI": "10.1016/S0140-6736(09)60237-3", "volume": "373", "author": "Ferrara", "year": "2009", "journal-title": "Lancet", "ISSN": "http://id.crossref.org/issn/0140-6736", "issn-type": "print"}, {"key": "15_47059184", "ISSN": "http://id.crossref.org/issn/0007-1048", "issn-type": "print", "volume": "160", "first-page": "133", "year": "2013", "journal-title": "British journal of haematology", "DOI": "10.1111/bjh.12115", "doi-asserted-by": "crossref"}, {"issue": "9", "key": "16_11367994", "doi-asserted-by": "publisher", "first-page": "495", "DOI": "10.1053/bbmt.2001.v7.pm11669216", "volume": "7", "author": "Akpek", "year": "2001", "journal-title": "Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation", "ISSN": "http://id.crossref.org/issn/1083-8791", "issn-type": "print"}, {"issue": "3", "key": "17_36626407", "doi-asserted-by": "publisher", "first-page": "241", "DOI": "10.1089/hum.2010.014", "volume": "21", "author": "Lupo-Stanghellini", "year": "2010", "journal-title": "Human gene therapy", "ISSN": "http://id.crossref.org/issn/1043-0342", "issn-type": "print"}, {"issue": "18", "key": "18_41154320", "doi-asserted-by": "publisher", "first-page": "1673", "DOI": "10.1056/NEJMoa1106152", "volume": "365", "author": "Di Stasi", "year": "2011", "journal-title": "New England Journal of Medicine", "ISSN": "http://id.crossref.org/issn/0028-4793", "issn-type": "print"}, {"issue": "7", "key": "19_37281157", "doi-asserted-by": "publisher", "first-page": "1330", "DOI": "10.1038/mt.2010.83", "volume": "18", "author": "Vogler", "year": "2010", "journal-title": "Molecular therapy : the journal of the American Society of Gene Therapy", "ISSN": "http://id.crossref.org/issn/1525-0016", "issn-type": "print"}, {"issue": "2", "key": "20_30236264", "doi-asserted-by": "publisher", "first-page": "623", "DOI": "10.1073/pnas.0710198105", "volume": "105", "year": "2008", "journal-title": "PNAS", "ISSN": "http://id.crossref.org/issn/0027-8424", "issn-type": "print"}, {"issue": "4", "key": "21_42218276", "doi-asserted-by": "publisher", "first-page": "252", "DOI": "10.1038/nrc3239", "volume": "12", "author": "Pardoll", "year": "2012", "journal-title": "Nature reviews. Cancer", "ISSN": "http://id.crossref.org/issn/1474-175X", "issn-type": "print"}, {"issue": "11", "key": "22_41077311", "doi-asserted-by": "publisher", "first-page": "805", "DOI": "10.1038/nrc3153", "volume": "11", "author": "Sharma", "year": "2011", "journal-title": "Nature reviews. Cancer", "ISSN": "http://id.crossref.org/issn/1474-175X", "issn-type": "print"}, {"issue": "5", "key": "23_16085530", "doi-asserted-by": "publisher", "first-page": "541", "DOI": "10.1016/1074-7613(95)90125-6", "volume": "3", "author": "Tivol", "year": "1995", "journal-title": "Immunity", "ISSN": "http://id.crossref.org/issn/1074-7613", "issn-type": "print"}, {"issue": "2", "key": "24_10961498", "doi-asserted-by": "publisher", "first-page": "141", "DOI": "10.1016/S1074-7613(00)80089-8", "volume": "11", "author": "Nishimura", "year": "1999", "journal-title": "Immunity", "ISSN": "http://id.crossref.org/issn/1074-7613", "issn-type": "print"}, {"issue": "33", "key": "25_19690427", "doi-asserted-by": "publisher", "first-page": "11823", "DOI": "10.1073/pnas.0505497102", "volume": "102", "year": "2005", "journal-title": "PNAS", "ISSN": "http://id.crossref.org/issn/0027-8424", "issn-type": "print"}, {"issue": "21", "key": "26_19472013", "doi-asserted-by": "publisher", "first-page": "9543", "DOI": "10.1128/MCB.25.21.9543-9553.2005", "volume": "25", "author": "Parry", "year": "2005", "journal-title": "Molecular and Cellular Biology", "ISSN": "http://id.crossref.org/issn/0270-7306", "issn-type": "print"}, {"issue": "26", "key": "27_42776575", "doi-asserted-by": "publisher", "first-page": "2443", "DOI": "10.1056/NEJMoa1200690", "volume": "366", "author": "Topalian", "year": "2012", "journal-title": "New England Journal of Medicine", "ISSN": "http://id.crossref.org/issn/0028-4793", "issn-type": "print"}, {"issue": "8", "key": "28_37403976", "doi-asserted-by": "publisher", "first-page": "711", "DOI": "10.1056/NEJMoa1003466", "volume": "363", "year": "2010", "journal-title": "New England Journal of Medicine", "ISSN": "http://id.crossref.org/issn/0028-4793", "issn-type": "print"}, {"issue": "1", "key": "29_38835078", "doi-asserted-by": "publisher", "first-page": "266", "DOI": "10.1073/pnas.1016791108", "volume": "108", "year": "2011", "journal-title": "PNAS", "ISSN": "http://id.crossref.org/issn/0027-8424", "issn-type": "print"}, {"issue": "7235", "key": "30_32935844", "doi-asserted-by": "publisher", "first-page": "206", "DOI": "10.1038/nature07662", "volume": "458", "author": "Velu", "year": "2009", "journal-title": "Nature; Physical Science (London)", "ISSN": "http://id.crossref.org/issn/1476-4687", "issn-type": "print"}, {"issue": "19", "key": "31_19449175", "doi-asserted-by": "publisher", "first-page": "9080", "DOI": "10.1158/0008-5472.CAN-05-0436", "volume": "65", "author": "Gade", "year": "2005", "journal-title": "Cancer Research", "ISSN": "http://id.crossref.org/issn/0008-5472", "issn-type": "print"}, {"issue": "4", "key": "32_45568933", "doi-asserted-by": "publisher", "first-page": "388", "DOI": "10.1158/2159-8290.CD-12-0548", "volume": "3", "year": "2013", "journal-title": "Cancer Discovery", "ISSN": "http://id.crossref.org/issn/2159-8274", "issn-type": "print"}, {"issue": "4", "key": "33_21887923", "doi-asserted-by": "publisher", "first-page": "628", "DOI": "10.1007/s00268-005-0544-5", "volume": "30", "author": "Kinoshita", "year": "2006", "journal-title": "World journal of surgery", "ISSN": "http://id.crossref.org/issn/0364-2313", "issn-type": "print"}, {"issue": "1", "key": "34_11453606", "doi-asserted-by": "publisher", "first-page": "70", "DOI": "10.1038/nbt0102-70", "volume": "20", "author": "Maher", "year": "2002", "journal-title": "Nature biotechnology", "ISSN": "http://id.crossref.org/issn/1087-0156", "issn-type": "print"}, {"key": "35_21816631", "doi-asserted-by": "publisher", "first-page": "65", "DOI": "10.1146/annurev.immunol.24.021605.090535", "volume": "24", "author": "Teft", "year": "2006", "journal-title": "Annual review of immunology", "ISSN": "http://id.crossref.org/issn/0732-0582", "issn-type": "print"}, {"issue": "7", "key": "36_37841854", "doi-asserted-by": "publisher", "first-page": "e11867", "DOI": "10.1371/journal.pone.0011867", "volume": "5", "author": "Fu", "year": "2010", "ISSN": "http://id.crossref.org/issn/1932-6203", "issn-type": "print"}, {"issue": "18", "key": "37_29408413", "doi-asserted-by": "publisher", "first-page": "5426", "DOI": "10.1158/1078-0432.CCR-07-0674", "volume": "13", "year": "2007", "journal-title": "Clinical Cancer Research", "ISSN": "http://id.crossref.org/issn/1078-0432", "issn-type": "print"}, {"issue": "17", "key": "38_36688501", "doi-asserted-by": "publisher", "first-page": "3508", "DOI": "10.1182/blood-2009-09-241398", "volume": "115", "year": "2010", "journal-title": "Blood", "ISSN": "http://id.crossref.org/issn/0006-4971", "issn-type": "print"}, {"issue": "2", "key": "39_18253224", "doi-asserted-by": "crossref", "first-page": "945", "DOI": "10.4049/jimmunol.173.2.945", "volume": "173", "author": "Chemnitz", "year": "2004", "journal-title": "The Journal of Immunology", "ISSN": "http://id.crossref.org/issn/0022-1767", "issn-type": "print"}, {"issue": "6", "key": "40_42659947", "doi-asserted-by": "publisher", "first-page": "1201", "DOI": "10.1084/jem.20112741", "volume": "209", "year": "2012", "journal-title": "Journal of Experimental Medicine", "ISSN": "http://id.crossref.org/issn/0022-1007", "issn-type": "print"}, {"issue": "3", "key": "41_31721596", "doi-asserted-by": "publisher", "first-page": "344", "DOI": "10.1016/j.coi.2008.03.005", "volume": "20", "author": "Bryceson", "year": "2008", "journal-title": "Current opinion in immunology", "ISSN": "http://id.crossref.org/issn/0952-7915", "issn-type": "print"}, {"issue": "111", "key": "42_41316502", "doi-asserted-by": "publisher", "first-page": "111ra120", "DOI": "10.1126/scitranslmed.3003130", "volume": "3", "author": "Amarnath", "year": "2011", "journal-title": "Science Translational Medicine", "ISSN": "http://id.crossref.org/issn/1946-6234", "issn-type": "print"}, {"key": "43_31829758", "doi-asserted-by": "publisher", "first-page": "141", "DOI": "10.1111/j.1600-065X.2008.00649.x", "volume": "224", "author": "Peggs", "year": "2008", "journal-title": "Immunological reviews", "ISSN": "http://id.crossref.org/issn/0105-2896", "issn-type": "print"}, {"issue": "2", "key": "44_30339626", "doi-asserted-by": "publisher", "first-page": "153", "DOI": "10.1038/nri2253", "volume": "8", "author": "Rudd", "year": "2008", "journal-title": "Nature reviews. Immunology", "ISSN": "http://id.crossref.org/issn/1474-1733", "issn-type": "print"}, {"issue": "12", "key": "45_38812745", "doi-asserted-by": "publisher", "first-page": "1248", "DOI": "10.1038/nbt1210-1248", "volume": "28", "author": "Uhlen", "year": "2010", "journal-title": "Nature biotechnology", "ISSN": "http://id.crossref.org/issn/1087-0156", "issn-type": "print"}, {"issue": "45", "key": "46_32105278", "doi-asserted-by": "publisher", "first-page": "5869", "DOI": "10.1038/onc.2008.273", "volume": "27", "author": "Campoli", "year": "2008", "journal-title": "Oncogene", "ISSN": "http://id.crossref.org/issn/0950-9232", "issn-type": "print"}, {"issue": "8", "key": "47_31755019", "doi-asserted-by": "publisher", "first-page": "e2990", "DOI": "10.1371/journal.pone.0002990", "volume": "3", "author": "Cui", "year": "2008", "ISSN": "http://id.crossref.org/issn/1932-6203", "issn-type": "print"}, {"issue": "7", "key": "48_29177260", "doi-asserted-by": "publisher", "first-page": "e660", "DOI": "10.1371/journal.pone.0000660", "volume": "2", "author": "Singh", "year": "2007", "ISSN": "http://id.crossref.org/issn/1932-6203", "issn-type": "print"}, {"issue": "1", "key": "49_36510673", "doi-asserted-by": "publisher", "first-page": "282", "DOI": "10.1007/s12032-009-9400-z", "volume": "28", "author": "Meimei", "year": "2011", "journal-title": "Medical oncology (Northwood, London, England)", "ISSN": "http://id.crossref.org/issn/1357-0560", "issn-type": "print"}, {"issue": "4", "key": "50_42189030", "doi-asserted-by": "publisher", "first-page": "224", "DOI": "10.1016/j.molmed.2012.02.001", "volume": "18", "author": "Tsuboi", "year": "2012", "journal-title": "Trends in molecular medicine", "ISSN": "http://id.crossref.org/issn/1471-4914", "issn-type": "print"}, {"issue": "2", "key": "51_22353430", "doi-asserted-by": "publisher", "first-page": "135", "DOI": "10.1679/aohc.69.135", "volume": "69", "author": "Tsuchiya", "year": "2006", "journal-title": "Archives of histology and cytology", "ISSN": "http://id.crossref.org/issn/0914-9465", "issn-type": "print"}, {"issue": "6024", "key": "52_39526223", "doi-asserted-by": "publisher", "first-page": "1559", "DOI": "10.1126/science.1203543", "volume": "331", "author": "Chaffer", "year": "2011", "journal-title": "Science", "ISSN": "http://id.crossref.org/issn/0036-8075", "issn-type": "print"}, {"issue": "12", "key": "53_30338202", "doi-asserted-by": "publisher", "first-page": "1440", "DOI": "10.1038/nm1676", "volume": "13", "author": "Stephan", "year": "2007", "journal-title": "Nature medicine", "ISSN": "http://id.crossref.org/issn/1078-8956", "issn-type": "print"}, {"key": "54_36309313", "doi-asserted-by": "publisher", "first-page": "89", "DOI": "10.1007/978-1-60761-362-6_7", "volume": "612", "author": "Burshtyn", "year": "2010", "journal-title": "Methods in molecular biology (Clifton, N.J.)", "ISSN": "http://id.crossref.org/issn/1064-3745", "issn-type": "print"}, {"key": "55_47059185", "ISSN": "http://id.crossref.org/issn/1087-0156", "issn-type": "print", "volume": "31", "first-page": "928", "year": "2013", "journal-title": "Nature biotechnology", "DOI": "10.1038/nbt.2678", "doi-asserted-by": "crossref"}, {"issue": "2", "key": "56_18605569", "doi-asserted-by": "crossref", "first-page": "758", "DOI": "10.4049/jimmunol.174.2.758", "volume": "174", "author": "Yuan", "year": "2005", "journal-title": "The Journal of Immunology", "ISSN": "http://id.crossref.org/issn/0022-1767", "issn-type": "print"}], "container-title": ["Science Translational Medicine"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1126/scitranslmed.3006597", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 22]], "date-time": "2017-06-22T04:06:09Z", "timestamp": 1498104369000}, "score": 32.978928, "issued": {"date-parts": [[2013, 12, 11]]}, "references-count": 56, "journal-issue": {"published-online": {"date-parts": [[2013, 12, 11]]}, "published-print": {"date-parts": [[2013, 12, 11]]}, "issue": "215"}, "URL": "http://dx.doi.org/10.1126/scitranslmed.3006597", "relation": {"cites": []}, "ISSN": ["1946-6234", "1946-6242"], "issn-type": [{"value": "1946-6234", "type": "print"}, {"value": "1946-6242", "type": "electronic"}], "subject": ["General Medicine"]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T20:28:00Z", "timestamp": 1575232080131}, "reference-count": 104, "publisher": "American Society of Hematology", "issue": "10", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2018, 3, 8]]}, "abstract": "<jats:title>Abstract</jats:title>\n               <jats:p>Therapeutic T-cell engineering is emerging as a powerful approach to treat refractory hematological malignancies. Its most successful embodiment to date is based on the use of second-generation chimeric antigen receptors (CARs) targeting CD19, a cell surface molecule found in most B-cell leukemias and lymphomas. Remarkable complete remissions have been obtained with autologous T cells expressing CD19 CARs in patients with relapsed, chemo-refractory B-cell acute lymphoblastic leukemia, chronic lymphocytic leukemia, and non-Hodgkin lymphoma. Allogeneic CAR T cells may also be harnessed to treat relapse after allogeneic hematopoietic stem cell transplantation. However, the use of donor T cells poses unique challenges owing to potential alloreactivity. We review different approaches to mitigate the risk of causing or aggravating graft-versus-host disease (GVHD), including CAR therapies based on donor leukocyte infusion, virus-specific T cells, T-cell receptor\u2013deficient T cells, lymphoid progenitor cells, and regulatory T cells. Advances in CAR design, T-cell selection and gene editing are poised to enable the safe use of allogeneic CAR T cells without incurring GVHD.</jats:p>", "DOI": "10.1182/blood-2017-08-752121", "type": "journal-article", "created": {"date-parts": [[2018, 1, 22]], "date-time": "2018-01-22T20:25:18Z", "timestamp": 1516652718000}, "page": "1045-1052", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 18, "title": ["Posttransplant chimeric antigen receptor therapy"], "prefix": "10.1182", "volume": "131", "author": [{"given": "Melody", "family": "Smith", "sequence": "first", "affiliation": [{"name": "Center for Cell Engineering and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY"}]}, {"given": "Johannes", "family": "Zakrzewski", "sequence": "additional", "affiliation": [{"name": "Center for Cell Engineering and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY"}]}, {"given": "Scott", "family": "James", "sequence": "additional", "affiliation": [{"name": "Center for Cell Engineering and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY"}]}, {"ORCID": "http://orcid.org/0000-0002-2846-6430", "authenticated-orcid": false, "given": "Michel", "family": "Sadelain", "sequence": "additional", "affiliation": [{"name": "Center for Cell Engineering and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY"}]}], "member": "234", "reference": [{"issue": "6", "key": "2019111904330821700_B1", "doi-asserted-by": "crossref", "first-page": "341", "DOI": "10.1016/S1083-8791(99)70010-8", "article-title": "Historical markers in the development of allogeneic hematopoietic cell transplantation", "volume": "5", "author": "Thomas", "year": "1999", "journal-title": "Biol Blood Marrow Transplant"}, {"issue": "17", "key": "2019111904330821700_B2", "doi-asserted-by": "crossref", "first-page": "1813", "DOI": "10.1056/NEJMra052638", "article-title": "Hematopoietic stem-cell transplantation", "volume": "354", "author": "Copelan", "year": "2006", "journal-title": "N Engl J Med"}, {"key": "2019111904330821700_B3", "author": "Thomas", "article-title": "One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood. 1977;49(4):511-533"}, {"issue": "22", "key": "2019111904330821700_B4", "doi-asserted-by": "crossref", "first-page": "2167", "DOI": "10.1056/NEJMra1609337", "article-title": "Acute graft-versus-host disease-biologic process, prevention, and therapy", "volume": "377", "author": "Zeiser", "year": "2017", "journal-title": "N Engl J Med"}, {"key": "2019111904330821700_B5", "author": "Martin", "first-page": "371", "year": "1990", "article-title": "T cell depletion for the prevention of graft-vs-host disease"}, {"issue": "12", "key": "2019111904330821700_B6", "doi-asserted-by": "crossref", "first-page": "3192", "DOI": "10.1182/blood.V98.12.3192", "article-title": "The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation", "volume": "98", "author": "Ho", "year": "2001", "journal-title": "Blood"}, {"issue": "7", "key": "2019111904330821700_B7", "doi-asserted-by": "crossref", "first-page": "871", "DOI": "10.1016/j.bbmt.2010.04.004", "article-title": "NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Transplantation", "volume": "16", "author": "Pavletic", "year": "2010", "journal-title": "Biol Blood Marrow Transplant"}, {"issue": "1 Suppl", "key": "2019111904330821700_B8", "doi-asserted-by": "crossref", "first-page": "S138", "DOI": "10.1016/j.bbmt.2009.10.023", "article-title": "Relapse after allogeneic hematopoietic cell therapy", "volume": "16", "author": "van den Brink", "year": "2010", "journal-title": "Biol Blood Marrow Transplant"}, {"issue": "5", "key": "2019111904330821700_B9", "doi-asserted-by": "crossref", "first-page": "2041", "DOI": "10.1182/blood.V86.5.2041.bloodjournal8652041", "article-title": "Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients", "volume": "86", "author": "Kolb", "year": "1995", "journal-title": "Blood"}, {"issue": "2", "key": "2019111904330821700_B10", "doi-asserted-by": "crossref", "first-page": "433", "DOI": "10.1200/JCO.1997.15.2.433", "article-title": "Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation", "volume": "15", "author": "Collins", "year": "1997", "journal-title": "J Clin Oncol"}, {"issue": "4", "key": "2019111904330821700_B11", "doi-asserted-by": "crossref", "first-page": "321", "DOI": "10.1016/j.hemonc.2017.05.002", "article-title": "Reduced-intensity versus myeloablative allogeneic transplantation", "volume": "10", "author": "Weisdorf", "year": "2017", "journal-title": "Hematol Oncol Stem Cell Ther"}, {"issue": "7655", "key": "2019111904330821700_B12", "doi-asserted-by": "crossref", "first-page": "423", "DOI": "10.1038/nature22395", "article-title": "Therapeutic T cell engineering", "volume": "545", "author": "Sadelain", "year": "2017", "journal-title": "Nature"}, {"issue": "3", "key": "2019111904330821700_B13", "doi-asserted-by": "crossref", "first-page": "279", "DOI": "10.1038/nm827", "article-title": "Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15", "volume": "9", "author": "Brentjens", "year": "2003", "journal-title": "Nat Med"}, {"issue": "9", "key": "2019111904330821700_B14", "doi-asserted-by": "crossref", "first-page": "3392", "DOI": "10.1172/JCI80010", "article-title": "CAR therapy: the CD19 paradigm", "volume": "125", "author": "Sadelain", "year": "2015", "journal-title": "J Clin Invest"}, {"issue": "95", "key": "2019111904330821700_B15", "doi-asserted-by": "crossref", "first-page": "95ra73", "DOI": "10.1126/scitranslmed.3002842", "article-title": "T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia", "volume": "3", "author": "Kalos", "year": "2011", "journal-title": "Sci Transl Med"}, {"issue": "18", "key": "2019111904330821700_B16", "doi-asserted-by": "crossref", "first-page": "4817", "DOI": "10.1182/blood-2011-04-348540", "article-title": "Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias", "volume": "118", "author": "Brentjens", "year": "2011", "journal-title": "Blood"}, {"issue": "8", "key": "2019111904330821700_B17", "doi-asserted-by": "crossref", "first-page": "725", "DOI": "10.1056/NEJMoa1103849", "article-title": "Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia", "volume": "365", "author": "Porter", "year": "2011", "journal-title": "N Engl J Med"}, {"issue": "177", "key": "2019111904330821700_B18", "doi-asserted-by": "crossref", "first-page": "177ra38", "DOI": "10.1126/scitranslmed.3005930", "article-title": "CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia", "volume": "5", "author": "Brentjens", "year": "2013", "journal-title": "Sci Transl Med"}, {"issue": "16", "key": "2019111904330821700_B19", "doi-asserted-by": "crossref", "first-page": "1509", "DOI": "10.1056/NEJMoa1215134", "article-title": "Chimeric antigen receptor-modified T cells for acute lymphoid leukemia", "volume": "368", "author": "Grupp", "year": "2013", "journal-title": "N Engl J Med"}, {"issue": "224", "key": "2019111904330821700_B20", "doi-asserted-by": "crossref", "first-page": "224ra25", "DOI": "10.1126/scitranslmed.3008226", "article-title": "Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia", "volume": "6", "author": "Davila", "year": "2014", "journal-title": "Sci Transl Med"}, {"issue": "16", "key": "2019111904330821700_B21", "doi-asserted-by": "crossref", "first-page": "1507", "DOI": "10.1056/NEJMoa1407222", "article-title": "Chimeric antigen receptor T cells for sustained remissions in leukemia", "volume": "371", "author": "Maude", "year": "2014", "journal-title": "N Engl J Med"}, {"issue": "6", "key": "2019111904330821700_B22", "doi-asserted-by": "crossref", "first-page": "540", "DOI": "10.1200/JCO.2014.56.2025", "article-title": "Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor", "volume": "33", "author": "Kochenderfer", "year": "2015", "journal-title": "J Clin Oncol"}, {"issue": "9967", "key": "2019111904330821700_B23", "doi-asserted-by": "crossref", "first-page": "517", "DOI": "10.1016/S0140-6736(14)61403-3", "article-title": "T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial", "volume": "385", "author": "Lee", "year": "2015", "journal-title": "Lancet"}, {"issue": "303", "key": "2019111904330821700_B24", "doi-asserted-by": "crossref", "first-page": "303ra139", "DOI": "10.1126/scitranslmed.aac5415", "article-title": "Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia", "volume": "7", "author": "Porter", "year": "2015", "journal-title": "Sci Transl Med"}, {"key": "2019111904330821700_B25", "doi-asserted-by": "crossref", "first-page": "570", "DOI": "10.1182/asheducation-2014.1.570", "article-title": "Maximizing GVL in allogeneic transplantation: role of donor lymphocyte infusions", "volume": "2014", "author": "Nikiforow", "year": "2014", "journal-title": "Hematology Am Soc Hematol Educ Program"}, {"issue": "12", "key": "2019111904330821700_B26", "doi-asserted-by": "crossref", "first-page": "2462", "DOI": "10.1182/blood.V76.12.2462.2462", "article-title": "Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients", "volume": "76", "author": "Kolb", "year": "1990", "journal-title": "Blood"}, {"issue": "1", "key": "2019111904330821700_B27", "first-page": "12", "article-title": "Donor mononuclear cell infusions as therapy for B-cell lymphoproliferative disorder following allogeneic bone marrow transplant", "volume": "4", "author": "Porter", "year": "1994", "journal-title": "Transplant Sci"}, {"issue": "5", "key": "2019111904330821700_B28", "first-page": "975", "article-title": "Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation", "volume": "18", "author": "Porter", "year": "1996", "journal-title": "Bone Marrow Transplant"}, {"issue": "4", "key": "2019111904330821700_B29", "doi-asserted-by": "crossref", "first-page": "473", "DOI": "10.1517/14712598.2011.554811", "article-title": "Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation", "volume": "11", "author": "Roddie", "year": "2011", "journal-title": "Expert Opin Biol Ther"}, {"issue": "2", "key": "2019111904330821700_B30", "doi-asserted-by": "crossref", "first-page": "205", "DOI": "10.1016/j.beha.2008.02.007", "article-title": "Graft-versus-host disease after donor leukocyte infusions: presentation and management", "volume": "21", "author": "Frey", "year": "2008", "journal-title": "Best Pract Res Clin Haematol"}, {"issue": "25", "key": "2019111904330821700_B31", "doi-asserted-by": "crossref", "first-page": "4129", "DOI": "10.1182/blood-2013-08-519413", "article-title": "Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation", "volume": "122", "author": "Kochenderfer", "year": "2013", "journal-title": "Blood"}, {"issue": "10", "key": "2019111904330821700_B32", "doi-asserted-by": "crossref", "first-page": "1112", "DOI": "10.1200/JCO.2015.64.5929", "article-title": "Allogeneic T cells that express an anti-CD19 chimeric antigen receptor induce remissions of B-cell malignancies that progress after allogeneic hematopoietic stem-cell transplantation without causing graft-versus-host disease", "volume": "34", "author": "Brudno", "year": "2016", "journal-title": "J Clin Oncol"}, {"issue": "11", "key": "2019111904330821700_B33", "doi-asserted-by": "crossref", "first-page": "e1027469", "DOI": "10.1080/2162402X.2015.1027469", "article-title": "Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia", "volume": "4", "author": "Dai", "year": "2015", "journal-title": "OncoImmunology"}, {"issue": "9", "key": "2019111904330821700_B34", "doi-asserted-by": "crossref", "first-page": "3363", "DOI": "10.1172/JCI86721", "article-title": "Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells", "volume": "126", "author": "Kebriaei", "year": "2016", "journal-title": "J Clin Invest"}, {"issue": "2", "key": "2019111904330821700_B35", "doi-asserted-by": "crossref", "first-page": "242", "DOI": "10.1038/nm.4258", "article-title": "Donor CD19 CAR T cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity", "volume": "23", "author": "Ghosh", "year": "2017", "journal-title": "Nat Med"}, {"issue": "4", "key": "2019111904330821700_B36", "doi-asserted-by": "crossref", "first-page": "415", "DOI": "10.1016/j.ccell.2015.09.004", "article-title": "Structural design of engineered costimulation determines tumor rejection kinetics and persistence of CAR T cells", "volume": "28", "author": "Zhao", "year": "2015", "journal-title": "Cancer Cell"}, {"issue": "2", "key": "2019111904330821700_B37", "doi-asserted-by": "crossref", "first-page": "380", "DOI": "10.1016/j.immuni.2016.01.021", "article-title": "Distinct signaling of coreceptors regulates specific metabolism pathways and impacts memory development in CAR T cells [published correction appears in Immunity. 2016;44(3):712]", "volume": "44", "author": "Kawalekar", "year": "2016", "journal-title": "Immunity"}, {"issue": "10", "key": "2019111904330821700_B38", "doi-asserted-by": "crossref", "first-page": "1361", "DOI": "10.1182/blood-2015-08-664250", "article-title": "Murine allogeneic CD19 CAR T cells harbor potent antileukemic activity but have the potential to mediate lethal GVHD", "volume": "127", "author": "Jacoby", "year": "2016", "journal-title": "Blood"}, {"key": "2019111904330821700_B39", "doi-asserted-by": "crossref", "first-page": "449", "DOI": "10.1056/NEJMoa1709919", "article-title": "Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia", "volume": "378", "author": "Jae", "year": "2018", "journal-title": "N Engl J Med"}, {"issue": "6", "key": "2019111904330821700_B40", "doi-asserted-by": "crossref", "first-page": "2123", "DOI": "10.1172/JCI85309", "article-title": "CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients", "volume": "126", "author": "Turtle", "year": "2016", "journal-title": "J Clin Invest"}, {"issue": "24", "key": "2019111904330821700_B41", "doi-asserted-by": "crossref", "first-page": "3750", "DOI": "10.1182/blood-2014-01-552174", "article-title": "Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15", "volume": "123", "author": "Xu", "year": "2014", "journal-title": "Blood"}, {"issue": "25", "key": "2019111904330821700_B42", "doi-asserted-by": "crossref", "first-page": "3322", "DOI": "10.1182/blood-2017-02-769208", "article-title": "Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults", "volume": "129", "author": "Gardner", "year": "2017", "journal-title": "Blood"}, {"issue": "5067", "key": "2019111904330821700_B43", "doi-asserted-by": "crossref", "first-page": "238", "DOI": "10.1126/science.1352912", "article-title": "Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones", "volume": "257", "author": "Riddell", "year": "1992", "journal-title": "Science"}, {"issue": "17", "key": "2019111904330821700_B44", "doi-asserted-by": "crossref", "first-page": "1185", "DOI": "10.1056/NEJM199404283301703", "article-title": "Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation", "volume": "330", "author": "Papadopoulos", "year": "1994", "journal-title": "N Engl J Med"}, {"issue": "10", "key": "2019111904330821700_B45", "doi-asserted-by": "crossref", "first-page": "679", "DOI": "10.1056/NEJM199409083311017", "article-title": "Donor T cells to treat EBV-associated lymphoma", "volume": "331", "author": "Heslop", "year": "1994", "journal-title": "N Engl J Med"}, {"issue": "16", "key": "2019111904330821700_B46", "doi-asserted-by": "crossref", "first-page": "1038", "DOI": "10.1056/NEJM199510193331603", "article-title": "Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor", "volume": "333", "author": "Walter", "year": "1995", "journal-title": "N Engl J Med"}, {"issue": "3", "key": "2019111904330821700_B47", "doi-asserted-by": "crossref", "first-page": "143", "DOI": "10.1016/j.bbmt.2003.09.017", "article-title": "Adoptive immunotherapy for posttransplantation viral infections", "volume": "10", "author": "Bollard", "year": "2004", "journal-title": "Biol Blood Marrow Transplant"}, {"issue": "19", "key": "2019111904330821700_B48", "doi-asserted-by": "crossref", "first-page": "4283", "DOI": "10.1182/blood-2009-07-232454", "article-title": "Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation", "volume": "114", "author": "Leen", "year": "2009", "journal-title": "Blood"}, {"issue": "9", "key": "2019111904330821700_B49", "doi-asserted-by": "crossref", "first-page": "983", "DOI": "10.1097/CJI.0b013e3181f3cbf4", "article-title": "Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma", "volume": "33", "author": "Louis", "year": "2010", "journal-title": "J Immunother"}, {"issue": "1", "key": "2019111904330821700_B50", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1080/10428190400002202", "article-title": "Adoptive immunotherapy for EBV-associated malignancies", "volume": "46", "author": "Gottschalk", "year": "2005", "journal-title": "Leuk Lymphoma"}, {"issue": "4", "key": "2019111904330821700_B51", "doi-asserted-by": "crossref", "first-page": "1123", "DOI": "10.1182/blood-2006-12-063008", "article-title": "Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial", "volume": "110", "author": "Haque", "year": "2007", "journal-title": "Blood"}, {"issue": "11", "key": "2019111904330821700_B52", "doi-asserted-by": "crossref", "first-page": "2644", "DOI": "10.1182/blood-2011-08-371971", "article-title": "Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation", "volume": "119", "author": "Doubrovina", "year": "2012", "journal-title": "Blood"}, {"issue": "22", "key": "2019111904330821700_B53", "doi-asserted-by": "crossref", "first-page": "4700", "DOI": "10.1182/blood-2010-06-289991", "article-title": "Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects", "volume": "116", "author": "Melenhorst", "year": "2010", "journal-title": "Blood"}, {"issue": "1", "key": "2019111904330821700_B54", "doi-asserted-by": "crossref", "first-page": "72", "DOI": "10.1182/blood-2011-07-366419", "article-title": "Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells", "volume": "119", "author": "Terakura", "year": "2012", "journal-title": "Blood"}, {"issue": "17", "key": "2019111904330821700_B55", "doi-asserted-by": "crossref", "first-page": "2965", "DOI": "10.1182/blood-2013-06-506741", "article-title": "Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study", "volume": "122", "author": "Cruz", "year": "2013", "journal-title": "Blood"}, {"issue": "5", "key": "2019111904330821700_B56", "doi-asserted-by": "crossref", "first-page": "807", "DOI": "10.1038/nm.2700", "article-title": "Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer", "volume": "18", "author": "Provasi", "year": "2012", "journal-title": "Nat Med"}, {"issue": "24", "key": "2019111904330821700_B57", "doi-asserted-by": "crossref", "first-page": "5697", "DOI": "10.1182/blood-2012-01-405365", "article-title": "A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR [published correction appears in Blood. 2015;126(22):2527]", "volume": "119", "author": "Torikai", "year": "2012", "journal-title": "Blood"}, {"issue": "6", "key": "2019111904330821700_B58", "doi-asserted-by": "crossref", "first-page": "539", "DOI": "10.1038/gt.2014.26", "article-title": "TALEN-mediated editing of endogenous T-cell receptors facilitates efficient reprogramming of T lymphocytes by lentiviral gene transfer", "volume": "21", "author": "Berdien", "year": "2014", "journal-title": "Gene Ther"}, {"key": "2019111904330821700_B59", "author": "Poirot", "year": "2015", "article-title": "Multiplex genome-edited T-cell manufacturing platform for \u201coff-the-shelf\u201d adoptive T-cell immunotherapies", "DOI": "10.1158/0008-5472.CAN-14-3321", "doi-asserted-by": "crossref"}, {"issue": "7643", "key": "2019111904330821700_B60", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1038/nature21405", "article-title": "Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection", "volume": "543", "author": "Eyquem", "year": "2017", "journal-title": "Nature"}, {"issue": "1", "key": "2019111904330821700_B61", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1038/nrm3486", "article-title": "TALENs: a widely applicable technology for targeted genome editing", "volume": "14", "author": "Joung", "year": "2013", "journal-title": "Nat Rev Mol Cell Biol"}, {"issue": "6213", "key": "2019111904330821700_B62", "doi-asserted-by": "crossref", "first-page": "1258096", "DOI": "10.1126/science.1258096", "article-title": "Genome editing. The new frontier of genome engineering with CRISPR-Cas9", "volume": "346", "author": "Doudna", "year": "2014", "journal-title": "Science"}, {"issue": "5", "key": "2019111904330821700_B63", "doi-asserted-by": "crossref", "first-page": "1117", "DOI": "10.1016/j.ymthe.2017.03.034", "article-title": "Chimeric antigen receptors: a cell and gene therapy perspective", "volume": "25", "author": "Rivi\u00e8re", "year": "2017", "journal-title": "Mol Ther"}, {"issue": "374", "key": "2019111904330821700_B64", "doi-asserted-by": "crossref", "first-page": "eaaj2013", "DOI": "10.1126/scitranslmed.aaj2013", "article-title": "Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells", "volume": "9", "author": "Qasim", "year": "2017", "journal-title": "Sci Transl Med"}, {"issue": "6", "key": "2019111904330821700_B65", "doi-asserted-by": "crossref", "first-page": "749", "DOI": "10.1016/S1074-7613(02)00474-0", "article-title": "Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro", "volume": "17", "author": "Schmitt", "year": "2002", "journal-title": "Immunity"}, {"issue": "1", "key": "2019111904330821700_B66", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1038/nri1257", "article-title": "T-cell development made simple", "volume": "4", "author": "Z\u00fa\u00f1iga-Pfl\u00fccker", "year": "2004", "journal-title": "Nat Rev Immunol"}, {"issue": "10", "key": "2019111904330821700_B67", "first-page": "979", "article-title": "Involvement of the c-kit receptor in the adhesion of hematopoietic stem cells to stromal cells", "volume": "22", "author": "Kodama", "year": "1994", "journal-title": "Exp Hematol"}, {"issue": "3", "key": "2019111904330821700_B68", "doi-asserted-by": "crossref", "first-page": "227", "DOI": "10.1016/j.bcmd.2004.08.007", "article-title": "Human bone marrow CD34+ progenitor cells mature to T cells on OP9-DL1 stromal cell line without thymus microenvironment", "volume": "33", "author": "De Smedt", "year": "2004", "journal-title": "Blood Cells Mol Dis"}, {"issue": "4", "key": "2019111904330821700_B69", "doi-asserted-by": "crossref", "first-page": "1431", "DOI": "10.1182/blood-2004-04-1293", "article-title": "Induction of T-cell development from human cord blood hematopoietic stem cells by Delta-like 1 in vitro", "volume": "105", "author": "La Motte-Mohs", "year": "2005", "journal-title": "Blood"}, {"issue": "5", "key": "2019111904330821700_B70", "doi-asserted-by": "crossref", "first-page": "972", "DOI": "10.1182/blood-2008-10-187013", "article-title": "Characterization in vitro and engraftment potential in vivo of human progenitor T cells generated from hematopoietic stem cells", "volume": "114", "author": "Awong", "year": "2009", "journal-title": "Blood"}, {"issue": "5", "key": "2019111904330821700_B71", "doi-asserted-by": "crossref", "first-page": "646", "DOI": "10.3324/haematol.2010.036343", "article-title": "T-lymphoid differentiation potential measured in vitro is higher in CD34+CD38-/lo hematopoietic stem cells from umbilical cord blood than from bone marrow and is an intrinsic property of the cells", "volume": "96", "author": "De Smedt", "year": "2011", "journal-title": "Haematologica"}, {"issue": "1", "key": "2019111904330821700_B72", "doi-asserted-by": "crossref", "first-page": "114", "DOI": "10.1016/j.stem.2012.11.002", "article-title": "Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiation", "volume": "12", "author": "Nishimura", "year": "2013", "journal-title": "Cell Stem Cell"}, {"issue": "10", "key": "2019111904330821700_B73", "doi-asserted-by": "crossref", "first-page": "928", "DOI": "10.1038/nbt.2678", "article-title": "Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy", "volume": "31", "author": "Themeli", "year": "2013", "journal-title": "Nat Biotechnol"}, {"issue": "5", "key": "2019111904330821700_B74", "doi-asserted-by": "crossref", "first-page": "531", "DOI": "10.1038/nmeth.4258", "article-title": "Progenitor T-cell differentiation from hematopoietic stem cells using Delta-like-4 and VCAM-1", "volume": "14", "author": "Shukla", "year": "2017", "journal-title": "Nat Methods"}, {"issue": "8", "key": "2019111904330821700_B75", "doi-asserted-by": "crossref", "first-page": "3579", "DOI": "10.1182/blood-2006-08-039842", "article-title": "Enhanced T-cell reconstitution by hematopoietic progenitors expanded ex vivo using the Notch ligand Delta1", "volume": "109", "author": "Dallas", "year": "2007", "journal-title": "Blood"}, {"issue": "8", "key": "2019111904330821700_B76", "doi-asserted-by": "crossref", "first-page": "1771", "DOI": "10.1002/stem.1145", "article-title": "Human T-lymphoid progenitors generated in a feeder-cell-free Delta-like-4 culture system promote T-cell reconstitution in NOD/SCID/\u03b3c(-/-) mice", "volume": "30", "author": "Reimann", "year": "2012", "journal-title": "Stem Cells"}, {"issue": "9", "key": "2019111904330821700_B77", "doi-asserted-by": "crossref", "first-page": "1039", "DOI": "10.1038/nm1463", "article-title": "Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation", "volume": "12", "author": "Zakrzewski", "year": "2006", "journal-title": "Nat Med"}, {"issue": "4", "key": "2019111904330821700_B78", "doi-asserted-by": "crossref", "first-page": "453", "DOI": "10.1038/nbt1395", "article-title": "Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors", "volume": "26", "author": "Zakrzewski", "year": "2008", "journal-title": "Nat Biotechnol"}, {"issue": "1", "key": "2019111904330821700_B79", "first-page": "157", "article-title": "Harnessing endogenous miR-181a to segregate transgenic antigen receptor expression in developing versus post-thymic T cells in murine hematopoietic chimeras", "volume": "119", "author": "Papapetrou", "year": "2009", "journal-title": "J Clin Invest"}, {"issue": "26", "key": "2019111904330821700_B80", "doi-asserted-by": "crossref", "first-page": "4210", "DOI": "10.1182/blood-2012-12-472803", "article-title": "Human proT-cells generated in vitro facilitate hematopoietic stem cell-derived T-lymphopoiesis in vivo and restore thymic architecture", "volume": "122", "author": "Awong", "year": "2013", "journal-title": "Blood"}, {"issue": "12", "key": "2019111904330821700_B81", "doi-asserted-by": "crossref", "first-page": "4716", "DOI": "10.1172/JCI60630", "article-title": "Extrathymic development of murine T cells after bone marrow transplantation", "volume": "122", "author": "Holland", "year": "2012", "journal-title": "J Clin Invest"}, {"key": "2019111904330821700_B82", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.3389/fimmu.2013.00163", "article-title": "The role of regulatory T cells in the biology of graft versus host disease", "volume": "4", "author": "Beres", "year": "2013", "journal-title": "Front Immunol"}, {"issue": "9", "key": "2019111904330821700_B83", "doi-asserted-by": "crossref", "first-page": "721", "DOI": "10.1158/2326-6066.CIR-16-0193", "article-title": "Regulatory T cells: differentiation and function", "volume": "4", "author": "Plitas", "year": "2016", "journal-title": "Cancer Immunol Res"}, {"issue": "5609", "key": "2019111904330821700_B84", "doi-asserted-by": "crossref", "first-page": "1057", "DOI": "10.1126/science.1079490", "article-title": "Control of regulatory T cell development by the transcription factor Foxp3", "volume": "299", "author": "Hori", "year": "2003", "journal-title": "Science"}, {"issue": "4", "key": "2019111904330821700_B85", "doi-asserted-by": "crossref", "first-page": "330", "DOI": "10.1038/ni904", "article-title": "Foxp3 programs the development and function of CD4+CD25+ regulatory T cells", "volume": "4", "author": "Fontenot", "year": "2003", "journal-title": "Nat Immunol"}, {"issue": "11", "key": "2019111904330821700_B86", "doi-asserted-by": "crossref", "first-page": "1311", "DOI": "10.1084/jem.193.11.1311", "article-title": "CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade", "volume": "193", "author": "Taylor", "year": "2001", "journal-title": "J Exp Med"}, {"issue": "3", "key": "2019111904330821700_B87", "doi-asserted-by": "crossref", "first-page": "389", "DOI": "10.1084/jem.20020399", "article-title": "Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation", "volume": "196", "author": "Hoffmann", "year": "2002", "journal-title": "J Exp Med"}, {"issue": "9", "key": "2019111904330821700_B88", "doi-asserted-by": "crossref", "first-page": "1144", "DOI": "10.1038/nm915", "article-title": "CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation", "volume": "9", "author": "Edinger", "year": "2003", "journal-title": "Nat Med"}, {"issue": "11", "key": "2019111904330821700_B89", "doi-asserted-by": "crossref", "first-page": "1688", "DOI": "10.1172/JCI17702", "article-title": "Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia", "volume": "112", "author": "Trenado", "year": "2003", "journal-title": "J Clin Invest"}, {"issue": "10", "key": "2019111904330821700_B90", "doi-asserted-by": "crossref", "first-page": "1374", "DOI": "10.1016/j.leukres.2009.11.024", "article-title": "Engineered regulatory T cells prevent graft-versus-host disease while sparing the graft-versus-leukemia effect after bone marrow transplantation", "volume": "34", "author": "Cao", "year": "2010", "journal-title": "Leuk Res"}, {"issue": "4", "key": "2019111904330821700_B91", "doi-asserted-by": "crossref", "first-page": "638", "DOI": "10.1182/blood-2014-03-564401", "article-title": "HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse", "volume": "124", "author": "Martelli", "year": "2014", "journal-title": "Blood"}, {"key": "2019111904330821700_B92", "author": "Brunstein", "year": "2016", "article-title": "Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile and clinical effect", "DOI": "10.1182/blood-2015-06-653667", "doi-asserted-by": "crossref"}, {"issue": "3", "key": "2019111904330821700_B93", "doi-asserted-by": "crossref", "first-page": "1245", "DOI": "10.4049/jimmunol.167.3.1245", "article-title": "CD4+CD25high regulatory cells in human peripheral blood", "volume": "167", "author": "Baecher-Allan", "year": "2001", "journal-title": "J Immunol"}, {"issue": "9", "key": "2019111904330821700_B94", "doi-asserted-by": "crossref", "first-page": "2598", "DOI": "10.1002/eji.200526077", "article-title": "Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation", "volume": "35", "author": "Albert", "year": "2005", "journal-title": "Eur J Immunol"}, {"issue": "1", "key": "2019111904330821700_B95", "doi-asserted-by": "crossref", "first-page": "347", "DOI": "10.4049/jimmunol.1402861", "article-title": "Donor requirements for regulatory T cell suppression of murine graft-versus-host disease", "volume": "195", "author": "Pierini", "year": "2015", "journal-title": "J Immunol"}, {"issue": "7", "key": "2019111904330821700_B96", "doi-asserted-by": "crossref", "first-page": "2014", "DOI": "10.1053/j.gastro.2008.02.060", "article-title": "Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice", "volume": "134", "author": "Elinav", "year": "2008", "journal-title": "Gastroenterology"}, {"issue": "1", "key": "2019111904330821700_B97", "doi-asserted-by": "crossref", "first-page": "112", "DOI": "10.1186/1742-2094-9-112", "article-title": "CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery", "volume": "9", "author": "Fransson", "year": "2012", "journal-title": "J Neuroinflammation"}, {"key": "2019111904330821700_B98", "author": "Yoon", "year": "2016"}, {"issue": "2", "key": "2019111904330821700_B99", "doi-asserted-by": "crossref", "first-page": "342", "DOI": "10.1042/BST20150247", "article-title": "Antigen-specificity using chimeric antigen receptors: the future of regulatory T-cell therapy?", "volume": "44", "author": "Boardman", "year": "2016", "journal-title": "Biochem Soc Trans"}, {"issue": "8", "key": "2019111904330821700_B100", "doi-asserted-by": "crossref", "first-page": "2871", "DOI": "10.1158/0008-5472.CAN-10-0552", "article-title": "In vivo inhibition of human CD19-targeted effector T cells by natural T regulatory cells in a xenotransplant murine model of B cell malignancy", "volume": "71", "author": "Lee", "year": "2011", "journal-title": "Cancer Res"}, {"issue": "4", "key": "2019111904330821700_B101", "doi-asserted-by": "crossref", "first-page": "1413", "DOI": "10.1172/JCI82771", "article-title": "Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor", "volume": "126", "author": "MacDonald", "year": "2016", "journal-title": "J Clin Invest"}, {"issue": "9", "key": "2019111904330821700_B102", "doi-asserted-by": "crossref", "first-page": "1088", "DOI": "10.1038/gt.2009.75", "article-title": "Redirecting human CD4+CD25+ regulatory T cells from the peripheral blood with pre-defined target specificity", "volume": "16", "author": "Hombach", "year": "2009", "journal-title": "Gene Ther"}, {"key": "2019111904330821700_B103", "author": "Delhove", "year": "2017", "article-title": "Genome-edited T cell therapies", "DOI": "10.1007/s40778-017-0077-5", "doi-asserted-by": "crossref"}, {"issue": "4", "key": "2019111904330821700_B104", "doi-asserted-by": "crossref", "first-page": "357", "DOI": "10.1016/j.stem.2015.03.011", "article-title": "New cell sources for T cell engineering and adoptive immunotherapy", "volume": "16", "author": "Themeli", "year": "2015", "journal-title": "Cell Stem Cell"}], "container-title": ["Blood"], "language": "en", "link": [{"URL": "http://ashpublications.org/blood/article-pdf/131/10/1045/1405453/blood752121.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "http://ashpublications.org/blood/article-pdf/131/10/1045/1405453/blood752121.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T09:34:02Z", "timestamp": 1574156042000}, "score": 32.887665, "issued": {"date-parts": [[2018, 3, 8]]}, "references-count": 104, "journal-issue": {"published-print": {"date-parts": [[2018, 3, 8]]}, "issue": "10"}, "URL": "http://dx.doi.org/10.1182/blood-2017-08-752121", "relation": {"cites": []}, "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}], "subject": ["Immunology", "Cell Biology", "Biochemistry", "Hematology"]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T21:54:58Z", "timestamp": 1574805298683}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Immunology Research"], "published-print": {"date-parts": [[2016, 6, 1]]}, "DOI": "10.1158/2326-6066.cir-16-0089", "type": "journal-article", "created": {"date-parts": [[2016, 6, 1]], "date-time": "2016-06-01T04:23:21Z", "timestamp": 1464755001000}, "page": "473-473", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Tales of Antigen Evasion from CAR Therapy"], "prefix": "10.1158", "volume": "4", "author": [{"given": "M.", "family": "Sadelain", "sequence": "first", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2016, 5, 31]]}, "container-title": ["Cancer Immunology Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/2326-6066.CIR-16-0089", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T14:35:28Z", "timestamp": 1482503728000}, "score": 32.04914, "issued": {"date-parts": [[2016, 5, 31]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2016, 5, 31]]}, "published-print": {"date-parts": [[2016, 6, 1]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.1158/2326-6066.cir-16-0089", "ISSN": ["2326-6066", "2326-6074"], "issn-type": [{"value": "2326-6066", "type": "print"}, {"value": "2326-6074", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T13:17:24Z", "timestamp": 1574774244914}, "reference-count": 12, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2016, 4, 1]], "date-time": "2016-04-01T00:00:00Z", "timestamp": 1459468800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Trends in Molecular Medicine"], "published-print": {"date-parts": [[2016, 4]]}, "DOI": "10.1016/j.molmed.2016.02.009", "type": "journal-article", "created": {"date-parts": [[2016, 3, 10]], "date-time": "2016-03-10T13:47:46Z", "timestamp": 1457617666000}, "page": "271-273", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Combinatorial Antigen Targeting: Ideal T-Cell Sensing and Anti-Tumor Response"], "prefix": "10.1016", "volume": "22", "author": [{"given": "Maria", "family": "Themeli", "sequence": "first", "affiliation": []}, {"given": "Michel", "family": "Sadelain", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Trends in Molecular Medicine"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1471491416000526?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1471491416000526?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 14]], "date-time": "2018-09-14T12:25:40Z", "timestamp": 1536927940000}, "score": 28.872047, "issued": {"date-parts": [[2016, 4]]}, "references-count": 12, "journal-issue": {"published-print": {"date-parts": [[2016, 4]]}, "issue": "4"}, "alternative-id": ["S1471491416000526"], "URL": "http://dx.doi.org/10.1016/j.molmed.2016.02.009", "ISSN": ["1471-4914"], "issn-type": [{"value": "1471-4914", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T08:16:12Z", "timestamp": 1574324172465}, "reference-count": 50, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2010, 2, 1]], "date-time": "2010-02-01T00:00:00Z", "timestamp": 1264982400000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/", "start": {"date-parts": [[2016, 10, 7]], "date-time": "2016-10-07T00:00:00Z", "timestamp": 1475798400000}, "delay-in-days": 2440, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Molecular Therapy"], "published-print": {"date-parts": [[2010, 2]]}, "DOI": "10.1038/mt.2009.210", "type": "journal-article", "created": {"date-parts": [[2009, 9, 22]], "date-time": "2009-09-22T14:06:44Z", "timestamp": 1253628404000}, "page": "413-420", "source": "Crossref", "is-referenced-by-count": 203, "title": ["Chimeric Antigen Receptors Combining 4-1BB and CD28 Signaling Domains Augment PI3kinase/AKT/Bcl-XL Activation and CD8+ T Cell\u2013mediated Tumor Eradication"], "prefix": "10.1016", "volume": "18", "author": [{"given": "Xiao-Song", "family": "Zhong", "sequence": "first", "affiliation": []}, {"given": "Maiko", "family": "Matsushita", "sequence": "additional", "affiliation": []}, {"given": "Jason", "family": "Plotkin", "sequence": "additional", "affiliation": []}, {"given": "Isabelle", "family": "Riviere", "sequence": "additional", "affiliation": []}, {"given": "Michel", "family": "Sadelain", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Molecular Therapy"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1525001616316240?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1525001616316240?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 16]], "date-time": "2018-12-16T21:20:47Z", "timestamp": 1544995247000}, "score": 28.755066, "issued": {"date-parts": [[2010, 2]]}, "references-count": 50, "journal-issue": {"published-print": {"date-parts": [[2010, 2]]}, "issue": "2"}, "alternative-id": ["S1525001616316240"], "URL": "http://dx.doi.org/10.1038/mt.2009.210", "ISSN": ["1525-0016"], "issn-type": [{"value": "1525-0016", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T08:31:03Z", "timestamp": 1574497863486}, "reference-count": 0, "publisher": "F1000 Research Ltd", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2010, 10, 28]]}, "DOI": "10.3410/f.5592956.5706055", "type": "dataset", "created": {"date-parts": [[2012, 8, 21]], "date-time": "2012-08-21T00:51:24Z", "timestamp": 1345510284000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Faculty of 1000 evaluation for Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA."], "prefix": "10.3410", "author": [{"given": "Michel", "family": "Sadelain", "sequence": "first", "affiliation": []}, {"given": "Eirini", "family": "Papapetrou", "sequence": "additional", "affiliation": []}], "member": "2560", "content-created": {"date-parts": [[2010, 10, 22]]}, "container-title": ["F1000 - Post-publication peer review of the biomedical literature"], "deposited": {"date-parts": [[2012, 8, 21]], "date-time": "2012-08-21T00:51:40Z", "timestamp": 1345510300000}, "score": 28.373299, "issued": {"date-parts": [[2010, 10, 22]]}, "references-count": 0, "URL": "http://dx.doi.org/10.3410/f.5592956.5706055"}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T05:48:21Z", "timestamp": 1574488101657}, "reference-count": 0, "publisher": "Begell House", "issue": "1-3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Crit Rev Immunol"], "published-print": {"date-parts": [[2001]]}, "DOI": "10.1615/critrevimmunol.v21.i1-3.160", "type": "journal-article", "created": {"date-parts": [[2012, 7, 14]], "date-time": "2012-07-14T03:17:39Z", "timestamp": 1342235859000}, "page": "13", "source": "Crossref", "is-referenced-by-count": 51, "title": ["A Unique Folate Hydrolase, Prostate-Specific Membrane Antigen (PSMA): A Target For Immunotherapy?"], "prefix": "10.1615", "volume": "21", "author": [{"given": "Jason", "family": "Tasch", "sequence": "first", "affiliation": []}, {"given": "Mike", "family": "Gong", "sequence": "additional", "affiliation": []}, {"given": "Michel", "family": "Sadelain", "sequence": "additional", "affiliation": []}, {"given": "Warren D. W.", "family": "Heston", "sequence": "additional", "affiliation": []}], "member": "613", "container-title": ["Critical Reviews\u2122 in Immunology"], "language": "en", "link": [{"URL": "https://dl.begellhouse.com/download/article/6a5b9a2d2ec1da76/article.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 15]], "date-time": "2019-02-15T13:23:13Z", "timestamp": 1550236993000}, "score": 27.337215, "issued": {"date-parts": [[2001]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2001]]}, "issue": "1-3"}, "URL": "http://dx.doi.org/10.1615/critrevimmunol.v21.i1-3.160", "ISSN": ["2162-6472"], "issn-type": [{"value": "2162-6472", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}